industry > industry > Pharmaceuticals Pharmaceuticals US FDA approves AstraZeneca's Crestor 09 February 2010 Scientists discover new treatment for chronic pain condition 08 February 2010 Newly engineered enzyme is a powerful staph antibiotic 06 February 2010 US FDA asks Ranbaxy to ensure plant standards compliance: report 05 February 2010 GlaxoSmithKline keeps jobs as 2009 profit jump 12 per cent to £8.73 billion 05 February 2010 Weight training improves cognitive function in seniors 05 February 2010 Rights groups contest human gene patent in US court 04 February 2010 GlaxoSmithKline inks up to $330 million drug deal with Apeiron Biologics 03 February 2010 Boston Scientific to pay J&J $1.73 billion in patent settlement 02 February 2010 Cephalon to acquire Swiss generic firm Mepha for $590 million 01 February 2010 GlaxoSmithKline may follow AstraZeneca in axing jobs: report 01 February 2010 Lupin receives US FDA approval for perindopril erbumine tablets 29 January 2010 Vitamin D can contribute to inflammatory bowel disease 29 January 2010 AstraZeneca reports profit, cuts 8,000 jobs to cut costs 29 January 2010 Enzon stockholders approve sale of specialty pharmaceutical business 28 January 2010 Widely used anti-obesity drug Sibutramine under FDA scanner 25 January 2010 Medtronic to acquire Invatec for $350 million 25 January 2010 Bayer to abandon haemophilia drug trial 25 January 2010 Researchers create new 'smart' nanocapsule delivery system for use in protein therapy 21 January 2010 Dr Reddy’ Labs posts consolidated net loss of Rs522 crore 21 January 2010 Alcon directors deride Novartis offer as grossly inadequate 20 January 2010 Ranbaxy acquires Biovel to enter vaccines business 19 January 2010 Bombay HC rejects plea to block Wockhardt deal with Abbott 18 January 2010 J&J adds several popular brands to Tylenol recall lots 16 January 2010 US justice dept hauls J&J to court for paying kickbacks 16 January 2010 EC probes pharma patent settlements to stall generic launches 13 January 2010 Wockhardt receives US FDA approval for antibacterial Levofloxacin 13 January 2010 LyondellBasell's `Moplen' resin used to replace steel in cleaning equipment 11 January 2010 Ministry stays DGGI ban on Natco’s generic cancer drug 11 January 2010 GSK inching closer to deal with Dr Reddy's? 08 January 2010 EU launches probe against Lundbeck for stalling generic drugs 08 January 2010 Orchid receives tentative FDA approval for Alzheimer’s drug Memantine tablet 08 January 2010 AstraZeneca settles another Nexium patent litigation for US sales 07 January 2010 Pfizer to market 40 Strides Arcolab generic drugs in the US 07 January 2010 Wockhardt gets US FDA approval for Alzheimer's drug Memantine 06 January 2010 Dr Reddy’s all-new diabetes drug shows good results 06 January 2010 Germany's Merz Pharmaceuticals to acquire BioForm Medical for $253 million 04 January 2010 Novartis acquires 52 per cent additional stake in Alcon for $28.1 billion 04 January 2010 Sun fails to dislodge Taro directors at general body 01 January 2010 Ranbaxy sells Chinese JV stake to state-owned firm 29 December 2009 Dr Reddy's to launch new drugs to boost domestic operations 28 December 2009 DCGI asks GSK to withdraw promotional campaign 26 December 2009 Ranbaxy again feels FDA heat – this time over US plant 26 December 2009 Teva-Kowa Pharma to acquire majority stake in Japanese genrics maker Taisho 24 December 2009 Boston Scientific pays $22 million to settle DOJ probe on kickbacks 24 December 2009 AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs 24 December 2009 Novartis acquires Corthera, gets global rights to new heart drug 23 December 2009 Glass Lewis supports Sun in Taro battle 23 December 2009 Lupin settles dispute with Forest Labs over Namenda 22 December 2009 Templeton cold to Taro’s plea for protection against Sun 22 December 2009 Seattle Genetics in antibody development deal with GSK 22 December 2009 Sanofi-aventis to acquire Chattem for $1.9 billion 21 December 2009 Ranbaxy to launch anti-hypertensive drug in six African countries 21 December 2009 Eli Lilly wins drug patent case vs Dr Reddy's in UK 18 December 2009 Sun Pharma advises Taro shareholders against voting at AGM 18 December 2009 India's FY09 pharma exports up 25 per cent at Rs38,433 crore 17 December 2009 J&J to buy ENT device maker Acclarent for $785 million 17 December 2009 Hospira of US buys Orchid’s injectables business 16 December 2009 Abbott to acquire Starlims Technologies for $123 million 15 December 2009 GSK and Intercell to develop innovative needle-free patch-based vaccines 12 December 2009 Taro again warns shareholders to stay away from Sun 12 December 2009 GlaxoSmithkline suspends operations at Andhra unit 11 December 2009 Glaxo targets emerging markets for acquisitions, tie-ups 11 December 2009 Biocon, HCG hospitals team up to fight cervical cancer 10 December 2009 EU raids pharmaceutical companies for anti-competitive business deals 10 December 2009 EKO Diagnostics to provide PET biomarkers to Siemens in Kolkata 09 December 2009 Ranbaxy exits JV with Japan’s Nippon Chemiphar 09 December 2009 Cipla gets notice for overpricing drugs; denies liability 08 December 2009 Celgene to acquire Gloucester Pharmaceuticals for $640 million 08 December 2009 Templeton switches sides; backs Sun on Taro takeover 02 December 2009 Genzyme starts shipments of drugs for two rare disorders 02 December 2009 Bayer Schering Pharma, Micromet to collaborate on developing new cancer antibody 02 December 2009 Pfizer inks $115 million deal with Israel’s Protalix for treatment of Gaucher’s disease 02 December 2009 Jubilant and Eli Lilly extend collaboration for five years 01 December 2009 Wockhardt settles with lender DBS Bank out of court 30 November 2009 Sanofi-Aventis signs drug localisation pact with Russia 28 November 2009 Ranbaxy launches generic herpes drug in US 27 November 2009 Sun Pharma gets FDA nod for selling generic drug 27 November 2009 Novartis gains rights to two oral investigational therapies for life-threatening blood disorders, cancers 25 November 2009 General Atlantic may buy stake in Strides Arcolab 24 November 2009 Merck wins summary judgment in Vioxx lawsuit in Texas 23 November 2009 Merck receives FDA approval for new fertility drug for women 21 November 2009 US FDA clears Boston Scientific's fully covered oesophageal stent 21 November 2009 Bristol-Myers to divest Mead Johnson for $7.69 billion 16 November 2009 Glenmark gets nod to market skin cream in US 16 November 2009 Cipla launches generic drugs for swine flu treatment 14 November 2009 Torrent opens exclusive human insulin unit for Novo Nordisk 14 November 2009 Aurbindo to merge subsidiary Trident Life Sciences Ltd 13 November 2009 Pfizer to slash R&D facilities post Wyeth merger 11 November 2009 Sanofi-Aventis expands Regeneron research deal to $1 billion 11 November 2009 India wins two creative Global Awards for healthcare communcations 11 November 2009 Enzon to sell specialty pharma business 09 November 2009 Dr Reddy's seeks US marketing rights for `Lipitor' generic 07 November 2009 J&J to axe more than 7,000 jobs in restructuring 04 November 2009 Spurious drugs: government announces reward scheme for whistleblowers 03 November 2009 Wockhardt reports Rs54 crore Q3 net loss 31 October 2009 Cadila launches first indigenously prepared TB drug 31 October 2009 Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators 30 October 2009 Sun Pharma earnings decline less-than-expected, Cipla earnings jump 82 per cent on forex gains 29 October 2009 Ranbaxy posts Rs186.08 crore in Q2 profits 27 October 2009 Impressive Q2 results see Lupin net surge 38 per cent to Rs160 crore 27 October 2009 Astellas to terminate development of anti-human antibody for RA 26 October 2009 EU watchdog places Biogen’s Tysabri under scanner 24 October 2009 Dr Reddy's July-September net zooms 106 per cent to Rs217 crore 23 October 2009 Pfizer unit fined record $1.3 billion for drug misbranding 19 October 2009 Pfizer completes Wyeth acquisition 16 October 2009 Eli Lilly to hive off Tippecanoe laboratory to Evonik Industries 15 October 2009 Suven Life's Alzheimer's drug candidate granted patents in 9 markets 14 October 2009 Piramal Lifesciences to invest Rs200 crore in drug researh 14 October 2009 Merck KGaA acquires Banagalore bioscience firm 13 October 2009 Novartis enters into $265-million schizophrenia drug deal with Vanda 13 October 2009 Novartis acquires global marketing rights for new drug from Paratek 09 October 2009 FDA advisory committee recommends approval of Pfizer’s Selzentry for HIV 09 October 2009 EU official raid Ranbaxy French unit 08 October 2009 Global pharmaceutical market to exceed $825 billion in 2010, says IMS 08 October 2009 Securities Tribunal asks Daiichi to offer Rs160 per Zenotech share 08 October 2009 GSK receives orders for 440 million doses of H1N1 vaccine 06 October 2009 Ranbaxy to market Daiichi Sankyo products in Mexico 05 October 2009 Hunduja's Gulf Oil sells IDL Specialty Chemicals to Biocon 01 October 2009 Boston Scientific and Johnson & Johnson settle patent disputes 30 September 2009 Academia Sinica joins Eli Lilly's new TB drug discovery programme 30 September 2009 Israeli drug firm Taro sues Sun Pharma in US 30 September 2009 Wockhardt receives US FDA approval for prostrate drug 29 September 2009 Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies 29 September 2009 Lupin buys US rights for cholesterol drug Antara 29 September 2009 Abbott to acquire Belgian drug company Solvay for $6.6 billion 29 September 2009 Pharma giants worried about India’s generic expertise: Sharma 26 September 2009 Strides Arcolab launches H1N1 drug ‘Starflu’ 26 September 2009 US Army claims `modest' success with AIDS vaccine trials in Thailand 24 September 2009 Wockhardt is top Indian pharma patentee; bags government award 24 September 2009 Astellas files suit against Teva for patent infringement in the US 24 September 2009 Venus Remedies outlicenses drug to South Korean firm 23 September 2009 Bayer to supply WHO with drug for African sleeping sickness 23 September 2009 Eli Lilly unveils plans to speed drug development 23 September 2009 Pfizer, Wyeth to sell animal drugs business to Boehringer 23 September 2009 Increasing incomes to boost costly drug sales: FICCI 22 September 2009 Merck, Wellcome Trust tie up to make affordable drugs in India 19 September 2009 Glaxo seeking stake in Dr Reddy’s: report 18 September 2009 Orchid receives USFDA approval for Zaleplon capsules 18 September 2009 Natco Pharma launches H1N1 drug ‘Natflu’ 18 September 2009 Ranbaxy in-licenses cosmetic product Neuronox from Medy-Tox, South Korea 17 September 2009 Government opens window for retail sale of H1N1 drug 15 September 2009 Eli Lilly plans 5,500 job cuts to save $1 billion 15 September 2009 Suven Life Sciences secures 2 US patents for new chemicals 14 September 2009 BASF India board okays Ciba India merger 14 September 2009 Dr Reddy's scotches stake sale rumours 11 September 2009 Six new national pharmaceutical institutes to be set up on PPP model 11 September 2009 Biocon in hybrid drug development pact with Amylin 11 September 2009 Hyderabad’s Suven gets first payoff from Eli Lilly tie-up 08 September 2009 Sigma acquires Bristol-Myers Sqibb’s brands 07 September 2009 Aurobindo Pharma receives USFDA, Swissmedic approval for drugs 07 September 2009 States lose power to certify drug exports 07 September 2009 Ranbaxy launches authorised generic version of Validus's Rocaltrol 03 September 2009 GSK to test swine flu vaccine in India at selected sites 03 September 2009 LEO Pharma to Acquire Peplin for $287.5 million 03 September 2009 Bayer acquires two prescription dermatology product lines from SkinMedica in the US 03 September 2009 Dainippon Sumitomo close to buy US drug maker Sepracor 03 September 2009 Pfizer agrees to pay $2.3 billion to settle illegal marketing case 03 September 2009 Vivimed Labs completes buyback of FCCBs totalling $12.5 million 02 September 2009 Roche buys Lonza’s Singapore unit for $360 million 02 September 2009 AstraZeneca says its new anti-clotting drug better than Plavix 31 August 2009 Facet Biotech, Trubion in $196 million cancer drug deal 31 August 2009 Novartis moves Supreme Court on Glivec patent 29 August 2009 SC refuses to hear Roche's patent plea against Cipla 28 August 2009 Capital subsidy scheme for SSI pharma units to cover 179 items 27 August 2009 Cipla to raise Rs1500 crore; eyes Chinese partner 27 August 2009 Suven Life in talks with global pharma firms for its Alzheimer drug 25 August 2009 Ranbaxy's peptic ulcer drug cleared for US launch 25 August 2009 Warner Chilcott acquires P&G's global pharmaceuticals business for $3.1 billion 25 August 2009 Clinical trials for Valeant's shingles pain drug show no conclusive benefit 24 August 2009 Wockhardt completes sale of veterinary business to Vétoquinol 20 August 2009 Delhi High Court allows Cipla to sell generic cancer drug 19 August 2009 Panacea Biotec wins $222.37 million UNICEF contract for EasyFive vaccine 19 August 2009 Glenmark, Forest drug trial for COPD fails 19 August 2009 Glenmark faces GSK patent challenge in US over malaria drug 18 August 2009 Sun Pharma wins Gemzar patent motion against Eli Lilly in US court 18 August 2009 Aurobindo Pharma to acquire Trident Life Sciences 17 August 2009 Swine flu bolsters Indian pharma stocks 11 August 2009 Delhi HC rejects Reckitt Benkiser's claims against Wyeth 11 August 2009 India to crack down on fake Chinese drugs 11 August 2009 Merck, Schering-Plough shareholders approve $41-billion deal 10 August 2009 Pfizer, Mylan lower HIV drug prices for drug-resistant patients 08 August 2009 Aurobindo wins FDA nod for generic drug 08 August 2009 Dr Reddy's Lab launches skin patch pain reliever in India 06 August 2009 FDA bans Teva Animal Health’s veterinary drugs 03 August 2009 Sun Pharma settles Ethyol dispute with MedImmune 03 August 2009 Pfizer settles Trovan cases; pays $75 million to Nigerian state 31 July 2009 Sanofi-Aventis to acquire Merck's Merial stake for $4 billion 30 July 2009 Mylan says FDA approves its drug production 29 July 2009 Wockhardt sells its nutrition businesses to Abbott for $130 million 28 July 2009 Chinese-made fake Indian drugs hurt industry's image in Africa 28 July 2009 Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore 27 July 2009 Azad hints at nexus between private-public vaccine units 25 July 2009 Dr Reddy's Q1 revenue up 21 per cent at Rs1,818 crore; eyes Rs15,000 crore turnover by 2012-13 23 July 2009 Bristol-Myers to acquire biotechnology company Medarex for $2.4 billion 23 July 2009 Merck’s Q2 profit falls, but beats expectations 22 July 2009 Dr Reddy's first quarter 2009-10 net doubles to Rs239 crore 21 July 2009 EC approves Pfizer's $68-billion acquisition of Wyeth 18 July 2009 Daiichi's 'low' bid for Zenotech faces new hurdles 16 July 2009 Merck, Schering-Plough settle Vyotorin dispute with states 16 July 2009 No decision yet on bringing essential drug under price control 11 July 2009 Streptokinase, A Life Saving Drug, Developed in collaboration with CSIR launched for Indian Market 11 July 2009 Cadila Pharmaceuticals launches joint venture with Novavax in India 10 July 2009 Sun Pharma to license key escitalopram patent applications to Lundbeck 10 July 2009 NPPA asks Cipla to pay for overcharging on drugs 10 July 2009 Ranbaxy's US subsidiary recalls anti-acne drug from US market 10 July 2009 Researchers claim phenoxodiol kills rapidly proliferating T-cells 09 July 2009 After US FDA raid, Sun Pharma’s US subsidiary slashes half its workforce 07 July 2009 Pharma's biggest boost comes from removal of fringe benefit tax 07 July 2009 Novartis' patent aplication for cancer drug Glivec rejected 07 July 2009 J&J to invest $1.5 billion in Elan’s Alzheimer’s drugs 03 July 2009 Lupin announces acquisition of worldwide rights for its nasal spray, AllerNaze 01 July 2009 J&J awarded $1.67 billion in patent suit against Abbott Laboratories 30 June 2009 Cash-strapped Wockhardt sells veterinary arm to France’s Vetoquinol 29 June 2009 Sun Pharma puts up brave face after FDA crackdown 27 June 2009 Sanofi’s diabetes drug may increase cancer risk: European study 27 June 2009 US FDA seizes drugs from Sun Pharma subsidiary Caraco 26 June 2009 Genzyme confident of restarting virus-hit Allston plant by August 26 June 2009 Sandoz receives approval for first-ever Japanese biosimilar 25 June 2009 Pfizer sweetens bid for India arm to Rs830 per share 25 June 2009 GSK signs drug pact with Chroma Therapeutics 24 June 2009 FDA calls for immediate stop to use of Zicam Cold Remedy and associated products 19 June 2009 Clinical trials using humans must now be registered 18 June 2009 Watson Pharmaceuticals to acquire Arrow Group for $1.75 billion 17 June 2009 Genzyme Corp shuts key facility to clean plant contamination 17 June 2009 Glaxo ties up with Dr Reddy's for emerging markets 15 June 2009 Eli Lilly made false claims of Zyprexa effectiveness 15 June 2009 China pushes fake "Indian" drugs in Africa 10 June 2009 GSK in new venture pact with Shenzhen Neptunus to make influenza vaccines in China 09 June 2009 Zydus Cadilla files application for anti-diabetes drug 04 June 2009 Adcock Ingram drops plans to acquire Cipla Medpro SA 02 June 2009 Bayer HealthCare and Genzyme finalise strategic alliance agreement 02 June 2009 AstraZeneca, Merck & Co to in phase 1 cancer drug research 01 June 2009 Daiichi Sankyo to raise $3 billion in bonds to repay Ranbaxy’s acquisition loan 01 June 2009 Bristol-Myers Squibb may acquire minority stake in Irish biotech firm 01 June 2009 Ranbaxy holds breath as FDA scrutinises corrective action plan 30 May 2009 Sanofi-Aventis inks cancer drug research deal with Exelixis 29 May 2009 Novartis ups offer price for Indian arm to Rs450 per share 28 May 2009 Skyepharma's new asthma drug `Flutiform, accepted for FDA review 27 May 2009 Ranbaxy seeks to downplay Malvinder exit 25 May 2009 Malvinder Singh relinquishes charge of Ranbaxy; Daiichi takes over 25 May 2009 J&J plans buyout of Cougar Biotech for $1 billion 23 May 2009 Ranbaxy acquires rights for Ochoa Labs’ skincare products 22 May 2009 Dr Reddy’s reorganises drug discovery operation; receives approval for three INDs 21 May 2009 Pfizer to expand presence in generic drugs marketing 21 May 2009 Merck plans buy-back of 35 per cent equity at Rs435 a share 20 May 2009 Biovail buys Cambridge Lab’s Huntington's disease drug 19 May 2009 Piramal Life Sciences gets regulatory nod for studies on cancer molecule 13 May 2009 Lupin reaches settlement with Wyeth on patented drug 13 May 2009 India gears up to mass-produce H1N1 flu vaccine 13 May 2009 Biocon's Kiran Mazumdar Shaw to receive Nikkei Asia Prize 11 May 2009 Aurobindo gets Australian nod for cholesterol pills 11 May 2009 Wockhardt to hive off animal health care business 07 May 2009 Ranbaxy's anti-malaria molecule enters Phase III clinical trial 06 May 2009 Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt 06 May 2009 Jubilant signs research deal with Anglo-Swedish firm AstraZeneca 06 May 2009 Ranbaxy recalls Nitrofurantoin capsules in the US 02 May 2009 Wockhardt settles patent row with Orion Corporation 29 April 2009 Glenmark gets USFDA approval for cholesterol-lowering agent Ezetimibe 28 April 2009 Wockhardt reports Rs139 crore net loss in Q4'08 25 April 2009 WHO worried over drug-resistant malaria strain 25 April 2009 Cipla feels FDA heat: nine ‘deviations’ found 20 April 2009 GSK close to acquiring Stiefel Lab for $3 billion 20 April 2009 GSK, Pfizer to merge HIV businesses into a new company 17 April 2009 Natco, Dr Reddy’s tie up for cancer generics 16 April 2009 Proxy war heats up as Icahn calls for Amylin chairman’s resignation 16 April 2009 Sanofi to buy US cancer drug firm for about $500 million 15 April 2009 Pharmacy benefits manager Express Scripts buys peer NextRx for $4.68 billion 14 April 2009 Indian drug pricing regulator to launch national media campaign 14 April 2009 Glenmark’s molecule for pain disorders clear Phase I trials in Europe 13 April 2009 Pfizer seeks to increase stake in Indian arm 13 April 2009 Scottish and Chinese centres join hands for stem cell research 13 April 2009 FDA nod for Stride Arcolabs’ AIDS drug combo 11 April 2009 Lupin, Natco team up for generic launch of Shire's `Fosrenol' 09 April 2009 Genentech pulls drug from US market after health scare 09 April 2009 PPDI sells Piedmont R&D center; acquires Magen BioSciences 04 April 2009 Piramal Healthcare to shut down UK unit 02 April 2009 Glenmark to withdraw painkiller from US market 02 April 2009 Aurobindo's HIV drug, Ranbaxy's epillepsy drug get USFDA nod 01 April 2009 Wockhardt CMD Khorakiwala quits; Fortis takeover likely 01 April 2009 Cadilla’s ‘magic bullet’ polycap clears first big test 01 April 2009 Bayer sells 3 cancer drugs to Genzyme for $650 million 01 April 2009 Wockhardt’s debt hard pill to swallow for investors 01 April 2009 Ranbaxy to launch Daiichi's hypertension drug in India 31 March 2009 Zydus Cadila, Eli Lily tie up for cardiovascular drug research 30 March 2009 Glaxo, Sanofi in talks for Shanta Biotch takeover 30 March 2009 GSK eyes push into emerging markets through Asken buy 28 March 2009 After Matrix who will be delisted next? 28 March 2009 Novartis's open offer for Indian arm to begin on 14 May 27 March 2009 Strides Arcolab gets USFDA approval for its Bangalore facility 27 March 2009 US pharmaceutical company Hospira to cut 10 per cent of workforce 25 March 2009 Novartis makes open offer for 39 per cent in Indian arm 25 March 2009 Bristol-Myers, Syngene open new R&D facility 24 March 2009 UK, Australia okay drugs from Ranbaxy plant 24 March 2009 Hikal plans to take over its own pharma co 23 March 2009 J&J, GSK, Novartis eye world's top dermatologist Stiefel 21 March 2009 Dr Reddy’s pulling out of small global markets 21 March 2009 Dr Reddy’s sales in Russia and CIS top $150 million 19 March 2009 Aspirin can help prevent heart attacks, strokes 19 March 2009 Pfizer raises $13.5-billion debt to part finance Wyeth acquisition 18 March 2009 Astellas withdraws from race to acquire CV Therapeutics 16 March 2009 Cholesterol-lowering statins reduce severe asthma attacks and hospitalisations 16 March 2009 Matrix gets tentative US FDA nod for HIV inhibitor drug 13 March 2009 US court clears Dr Reddy’s in Omeprazole Mg OTC litigation 13 March 2009 Gilead Sciences to acquire CV Therapeutics for $1.4 billion 13 March 2009 Pharma majors under merger pressure after Merck-Schering deal 12 March 2009 Roche calls Genentech’s $112 a share demand unreasonable, may reach agreement on $95 a share 10 March 2009 Biocon arm Syngene in R&D pact with DuPont Crop Protection 09 March 2009 Merck to acquire Schering- Plough for $41 billion 09 March 2009 Pfizer sells insulin assets to Anti-diabetes drugmaker MannKind for $33 million 09 March 2009 Takeda shares plummet as FDA delays new drug 09 March 2009 Ranbaxy's cardio drug `Ramipril' gets US FDA approval 09 March 2009 Medicated patch can cause burns during MRI, warns FDA 09 March 2009 Roche raises Genentech offer from $86.50 to $93 a share 07 March 2009 New bill seeks to bring plants exporting drugs to US under FDA inspection 05 March 2009 Pfizer ties up with Aurobindo for generic drugs 04 March 2009 Pfizer acquires rights to several generics from Aurobindo 03 March 2009 Beckman to acquire Olympus unit for $800 million 02 March 2009 UK watchdog cautions parents giving cold and cough medicines to children 02 March 2009 Cephalon opens bid for Aussie bio-technology firm Arana 28 February 2009 Japan’s No.2 drugmaker Astellas makes $1-billion hostile bid for US firm CV Therapeutics 28 February 2009 US drug firm Cephalon makes $329 million offer for Australia's Arana 27 February 2009 Daiichi, Ranbaxy form team to face FDA charges 27 February 2009 Wockhardt to launch ulcer drug Ranitidine in the US 26 February 2009 Ranbaxy plant in India falsified data: US FDA 25 February 2009 Biogen in talks to acquire Acorda for multiple sclerosis pill 25 February 2009 Genentech tells shareholders to reject Roche bid 24 February 2009 Medtronic buys CoreValue, Ventor Technologies for $1.03 billion 24 February 2009 SC notice to Ramadoss on closure of public sector vaccine units 21 February 2009 Sale of Genentech skin drug `Raptiva' suspended after 3 deaths 20 February 2009 US, China in race for top slot in global wind industry 17 February 2009 Dutch minister promises a re-look at drug seizures on patent issues 11 February 2009 PPF ends opposition to Zentiva sale; Sanofi takeover likely 11 February 2009 Indian medicines made safer from patent piracy 10 February 2009 Medical world abuzz about cancer-killing CyberKnife 10 February 2009 Danish drugmaker Lundbeck to acquire Ovation of US for $900 million 09 February 2009 Piramal Healthcare denies reports of Glaxo, Sanofi bid 07 February 2009 Bird flu fears in China prompt extensive vaccination, closure of Hong Kong sanctuary 07 February 2009 Carl Icahn attempts to get nominees on Biogen board after blockbuster drug drags 07 February 2009 Government plans big push on generic drugs 06 February 2009 Glenmark receives approval from the US FDA for lithium carbonate capsules 05 February 2009 Schering-Plough’s quarterly results surpass expectations 04 February 2009 Study suggests insulin may be treatment for Alzeheimer's 03 February 2009 Troubled MDS may sell of divisions 03 February 2009 Pfizer discontinues global phase III trial of Axitinib for futility in advanced pancreatic cancer 31 January 2009 India, Brazil denounce seizure of medicines by Dutch authorities 31 January 2009 Amylin shares up as Icahn consolidates stake 31 January 2009 Roche lowers Genentech bid to $42 billion 30 January 2009 WHO shelves redefinintion amidst protest from Indian drug makers 27 January 2009 Pfizer-Wyeth create $68-billion blockbuster deal 27 January 2009 Glaxo buys UCB patents 24 January 2009 Stem cell study for spinal injury gets FDA nod 24 January 2009 Pfizer in talks to acquire Wyeth for $60 billion 23 January 2009 FDA woes hit Ranbaxy in Q4 23 January 2009 Unigene reports positive results on a novel peptide for reducing food consumption 21 January 2009 Ranbaxy affiliate Zenotech objects to open offer pricing 19 January 2009 India plans to move WTO as EU confiscates drugs in transit 16 January 2009 Eli Lilly to pay $1.42 billion to settle misdemeanor case regarding blockbuster drug Zyprexa 15 January 2009 Exact Sciences rebuffs Sequenom's $41 million buyout offer 13 January 2009 Abbott Laboratories acquires Advanced Medical Optics in $2.8 billion cash-and-debt deal 12 January 2009 American pharma major Wyeth looking to acquire Dutch vaccine maker Crucell 08 January 2009 Taro asks Sun to raise bid; proposes shareholder referendum 06 January 2009 Endo to acquire biopharma firm Indevus for $370 million 06 January 2009 Sun offers to buy Taro shares at a premium 05 January 2009 Daiichi Sankyo announces valuation loss for Ranbaxy acquisition of 359 billion yen 05 January 2009 Centre acquires controlling stake in 2 drug firms 02 January 2009 Pharma sales beat inflation 02 January 2009 American states receive million-dollar settlements from drugmaker Cephalon 31 December 2008 Amrutanjan to get makeover 26 December 2008 Piramal buys US-based Minrad to strengthen its position in anesthetics 24 December 2008 FDA warns consumers about tainted weight-loss products 23 December 2008 GlaxoSmithKline acquires Bristol-Myers Squibb Pakistan 22 December 2008 Aurobindo Pharma gets USFDA nod for anti-HIV drug 22 December 2008 Malvinder gets additional charge of chairman in reconstituted Ranbaxy board 20 December 2008 Wyeth acquires British biotech firm 19 December 2008 Infosys wins multi-million dollar AstraZeneca deal 15 December 2008 Pharmaceutical companies asked to pass excise benefits to consumers 15 December 2008 Bristol-Myers Squibb, Exelixis to collaborate on two novel cancer molecules 12 December 2008 Eli Lilly reports new product development on track 12 December 2008 Merck launches division for follow-on biotech drugs 11 December 2008 Pharma sector attracts Atlas Cycles and Shanku Group 06 December 2008 Research proves branded drugs not superior to generics 05 December 2008 Wockhardt gets US FDA approval for paediatrics drug 04 December 2008 Ranbaxy in pact to market BioPro's brain tumour drug in India 03 December 2008 Eli Lilly sues Lupin, Aurobindo for patent infringement 03 December 2008 J&J buys breast implant maker Mentor Corp for $1.07 billion 01 December 2008 Plethico to take 20 per cent stake in CIS drug maker 29 November 2008 Drugmaker Eli Lilly withdraws drug application to treat chronic pain 29 November 2008 Drug firms misusing patents to block cheaper generics: EU 28 November 2008 Sun Pharma's US arm acquires Chattem 27 November 2008 AstraZeneca, Abraxis rethink cancer drug deal 26 November 2008 Johnson & Johnson acquires Omrix Biopharmaceuticas for $465 million 25 November 2008 King Pharma to acquire Alpharma for around $1.6 billion 25 November 2008 Glenmark gets US FDA approval for marketing Ranitidine 21 November 2008 Sanofi settles Allegra, Nasacort patent suits with Teva, Barr 20 November 2008 AstraZeneca agrees to cut drug prices in UK, stock plummets 20 November 2008 Glenmark launches `Azathioprine' tablets in US 20 November 2008 Teva in bid to make generic version of Gilead's AIDS drug Truvada 15 November 2008 Wockhardt gets USFDA approval for insomnia drug sale 14 November 2008 US FDA observations not to affect drug sales: Lupin 14 November 2008 Zydus Cadila acquires Etna Biotech of Italy 11 November 2008 Glenmark starts selling pain killer drugs in US 10 November 2008 Sun Pharma extends offer for Taro till 19 December 10 November 2008 Amgen Positioned to Deliver Attractive Growth Over Next Five Years 08 November 2008 Daiichi Sankyo completes Ranbaxy acquisition 07 November 2008 Pfizer ends testing obesity drug on account of risk of US non-approval 06 November 2008 US Supreme Court split in Wyeth v/s Levine 05 November 2008 Genentech Submits application to US FDA for avastin for brain cancer treatment 04 November 2008 Sanofi's anti-obesity drug Acomplia pulled out of EU 25 October 2008 Exelixis says GSK drug research deal to end 24 October 2008 Eli Lily's suspension of arthritis drug development expected to hit Glenmark's pipeline 24 October 2008 Roche confirms plans to acquire remaining 44 per cent in Genentech 21 October 2008 Daiichi acquires 52.5 per cent in Ranbaxy 20 October 2008 Cadila gets USFDA approval antyi-depressant Risperidone 20 October 2008 Pfizer reaches $894 million settlement to resolve Bextra litigation 18 October 2008 Ranbaxy-Daiichi deal hits a regulatory bump 17 October 2008 Wockhardt gets US FDA nod to market Ceftazidime injections 16 October 2008 New anti-piracy law to be enacted in the US 15 October 2008 Abbott says its bioabsorbable drug-eluting stent could become next major breakthrough in interventional treatment 14 October 2008 Zydus Cadila receives WHO prequalification accreditation for Rabies vaccine 14 October 2008 Ipca Labs, US-based Heritage to market cardiovascular tablet, Propranolol in the US 13 October 2008 Ranbaxy-GSK submits IND application for respiratory inflammation candidate 13 October 2008 Chennai's Malladi Drugs to set up global hub in Malaysia 08 October 2008 Three scientists share Nobel prize for medicine 06 October 2008 Eli Lilly to acquire ImClone for $6.5 billion 06 October 2008 Jubilant in R&D, clinical trial joint venture with Eli Lilly 04 October 2008 Delayed approval of Ranbaxy deal brings $445 million windfall for Daiichi 04 October 2008 Mystery buyer Eli Lilly reported to outbid Bristol-Myers with $6.1 billion for ImClone 04 October 2008 Ely Lilly, Deciphera tie up for cancer drug research 03 October 2008 Advanced Life Sciences, Wyeth in Asian marketing pact for new drug 03 October 2008 US FDA probing deaths in German study involving J&J's anti-anemia drugs 03 October 2008 Emami woos Zandu shareholders by increasing offer price to Rs16,500 03 October 2008 Tata's Advinus Therapeutics, J&J arm in drug development pact 01 October 2008 Pharmaceutical offshoring to grow to Rs2,500 crore by 2012 29 September 2008 Orchid in pact with Merck & Co to develop novel anti-infective drugs 29 September 2008 Alpharma rejects King Pharmaceuticals’ $1.55 billion offer as inadequate 27 September 2008 Glenmark gets ANDA approval from US FDA for generic betamethasone corticosteroid 25 September 2008 Bristol-Myers Squibb raises bid for ImClone to $4.7 billion 23 September 2008 French pharma Sanofi-Aventis acquires Zentiva for $2.6 billion 23 September 2008 Ranbaxy hires New York ex-mayor Giuliani to resolve issues with US FDA 18 September 2008 Lupin acquires majority stake in South Africa's Pharma Dynamics 18 September 2008 US FDA bans import of over 30 Ranbaxy generic drugs 17 September 2008 Bayer acquires German biotech drug developer Direvo Biotech AG 16 September 2008 CSIR launches open source drug discovery 16 September 2008 Emami doubles offer price to Rs15,000 per Zandu share 15 September 2008 ImClone rejects Bristol-Myers Squibb's $4.3 billion bid; cites $6.1 billion fresh offer 10 September 2008 Essar Gujarat in petrochem technology licencing deal with CB&I 09 September 2008 Biocon says its oral insulin is good for Type 2 diabetes 08 September 2008 US FDA to list names of drugs under investigation 06 September 2008 Sun extends offer for Taro by a month as Israeli SC stays acquisition 04 September 2008 Maoists shut Dabur’s Nepal factory 04 September 2008 Japanese drug maker Shionogi to acquire American rival for $1.1 billion 02 September 2008 Fish oil better than AstraZeneca's Crestor says new heart-failure study 01 September 2008 Sun Pharma wins Taro takeover case in Israel 27 August 2008 Cabinet likely to clear Daiichi-Ranbaxy deal next month 26 August 2008 Lupin acquires stake in Australian pharma firm Generic Health 21 August 2008 Lupin in marketing alliance with Forest for asthma product 19 August 2008 Management expansion at McCann Healthcare Worldwide 19 August 2008 Methadone a double-edged painkiller 18 August 2008 Sun Pharma gets US regulator's approval for Taro open offer 14 August 2008 Orchid Pharma to make Merck's anti-coagulant drug 14 August 2008 Genentech rejects Roche’s $43.7-billion takeover offer as too low 13 August 2008 Australian pharma firm CSL buys US rival Talecris for $3.1 billion 13 August 2008 Dr Reddy's, Teva settle `carvedilol' patent dispute: report 12 August 2008 Panacea Biotec secures Rs143 crore UNICEF order for `EasyFive' vaccine 12 August 2008 Pfizer to settle Lipitor case with Canada's Apotex 11 August 2008 Finance ministry clears Daiichi-Ranbaxy deal among 24 FDI proposals 06 August 2008 Daiichi to launch open offer for Ranbaxy on 16 August 05 August 2008 Carl Icahn finds Bristol-Myers' offer for ImClone Systems low 04 August 2008 Orchid receives EU approvals for anti-bacterial injections Piperacillin, Tazobactam 04 August 2008 Bristol-Myers Squibb completes sell-off of ConvaTec to PE firms 04 August 2008 Ranbaxy applies for US FDA approval for Mohali plant; says WHO approves new ARV drug 02 August 2008 US FDA rejects Schering-Plough's post-surgery drug Sugammadex 01 August 2008 Bristol-Myers Squibb to acquire ImClone Systems for $4.5-billion 31 July 2008 Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets 31 July 2008 Sun set for a long battle for Taro 30 July 2008 Lupin enter Europe with acquisition of German pharma marketing agency Hormosan 30 July 2008 Ranbaxy banks on Pfizer settlement to revive falling fortunes 29 July 2008 After amlodipine in Japan, Ranbaxy launches omerprazole 28 July 2008 Agitators burn shed at Dow Chemical's construction site near Pune 26 July 2008 Roche bids for Genentech on Monday, acquires Mirus on Tuesday and Arius on Wednesday 25 July 2008 GlaxoSmithKline teams up with South Africa's Aspen to market branded generics 23 July 2008 Piramal Healthcare and Pierre Fabre launch French dermo cosmetic range in India 23 July 2008 US House representatives probe FDA approval of Ranbaxy drugs 23 July 2008 UK Crown court rejects charges against Ranbaxy 23 July 2008 Dr Reddy’s to buy back Perlecan Pharma stake from ICICI Ventures and Citigroup 22 July 2008 Bilcare Ltd, MeadWestVaco jointly acquire US pharmaceuticals packaging firm International Labs 21 July 2008 Sanofi-aventis to acquire Symbion Holdings for $544 million 21 July 2008 Roche makes a $43.7-billion bid for Genentech 21 July 2008 Clinton initiates cheap malaria drugs programme 19 July 2008 Biotechnology companies Genzyme and PTC Therapeutics ink $100 million deal 19 July 2008 No1 generic drugs maker Teva acquires rival Barr Pharma for $7.46 billion 18 July 2008 MNC rival trying to scuttle Daiichi deal: Ranbaxy 18 July 2008 Pakistan government blocks proposal to import Indian drugs 17 July 2008 FDA under probe as Ranbaxy says Daiichi deal is sealed 17 July 2008 Sun Pharma extends Taro tender offer 16 July 2008 Mark Mobius objects to Sun's acquisition of Taro 16 July 2008 Ranbaxy denies allegation of substandard drug sale; gets nod for stake sale 15 July 2008 Amgen to pay J&J's Ortho Biotech $200 million to settle suit 15 July 2008 Reports of coming under US FDA scanner hammer Ranbaxy stock 14 July 2008 India's first patent facilitation centre opens at Hyderabad 12 July 2008 Taro advises shareholders against Sun's open offer 11 July 2008 Novartis announces strategic partnership with Lonza to boost biologics pipeline 11 July 2008 Novartis to buy Swiss biotech company Speedel for $880 million 11 July 2008 Dr. Reddy's in global Ibuprofen marketing pact with Albemarle 09 July 2008 American drugmaker Eli Lilly buys biotech company SGX Pharma for $64 million 09 July 2008 Ahmedabad-based Veeda Oncology acquires International Oncology Network Clinical Research 08 July 2008 Fresenius to acquire APP Pharmaceuticals in $3.7-billion deal 07 July 2008 Ashok Kumar takes over as Secretary in the Department of Pharmaceuticals 07 July 2008 Panacea Biotec takes 75 per cent in Umkal to enter healthcare sector 05 July 2008 Cadila Healthcare to demerge consumer products division into Carnation, merge Zydus Hospitals with itself 05 July 2008 UK's Shire acquires maker of Firazyr, Jerini AG 04 July 2008 US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel 03 July 2008 Piramal Healthcare acquires PlasmaSelect's polygeline product Haemaccel 03 July 2008 Glenmark acquires 7 pharmaceutical brands in Poland 02 July 2008 Exelixis and GlaxoSmithKline to conclude six-year discovery and development collaboration 28 June 2008 FDA bars use of Merck's cancer vaccine by women over 27 26 June 2008 Sun goes ahead with Taro acquisition; files suit in US court 26 June 2008 Tentative nod from USFDA for Ranbaxy's cancer drug valganciclovir 26 June 2008 US FDA delays approval on new drug by Eli Lilly and Daiichi Sankyo 25 June 2008 Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid 23 June 2008 Johnson & Johnson Nordic AB acquires Åmic 23 June 2008 Taro sues Sun Pharma again; alleges plan to block sale of Irish arm 20 June 2008 Glenmark gets USFDA approval for anti-hypertensive, Trandolapril 20 June 2008 Top two shareholders, including Sanofi-Aventis, launch competing bids for Czech drugmaker Zentiva 19 June 2008 CNBC-TV18 shares with domain-b its exclusive interview with Malvinder Singh 18 June 2008 Pfizer and Ranbaxy settle global Lipitor patent litigation 18 June 2008 Cadila realigns consumer products division 18 June 2008 Boehringer Ingelheim to acquire Actimis Pharmaceuticals 18 June 2008 Daiichi to make open offer for Ranbaxy on August 8 16 June 2008 Bayer to make medicines from tobacco 16 June 2008 Sanofi commits 60 million doses of H5N1 vaccine for WHO global H5N1 vaccine stockpile 16 June 2008 Report on Pfizer move buoys Ranbaxy stock to a 3-year high 13 June 2008 Biotechnology giant Invitrogen plans to acquire peer Applied Biosystems for $6.7 billion 12 June 2008 Behind the Ranbaxy sale 12 June 2008 Glaxo to cut 350 R&D jobs in drug research revamp 11 June 2008 This is the start of a much larger game 11 June 2008 Ranbaxy struck deal at appropriate time: PwC 11 June 2008 Japan's Daiichi Sankyo to acquire majority stake in Ranbaxy 11 June 2008 Natco Pharma grants global marketing for its generic Copaxone to Mylan 10 June 2008 Taro selling Irish assets to thwart merger: Sun Pharma 06 June 2008 Biocon launches India's first pre-filled syringes 04 June 2008 Novartis buys US drug firm Protez for around $400 million 04 June 2008 Mylan Inc. acquires Merck KGaA's central eastern European generics businesses 02 June 2008 CuraGen presents encouraging results from ongoing Phase I / II study of CR011-vcMMAE in metastatic melanoma 02 June 2008 Emami buys 27.5 per cent in Zandu; to make open offer 31 May 2008 Bristol-Myers Squibb to buy anti-cancer drug maker Kosan Biosciences for $190 million 30 May 2008 Glenmark gets nod for marketing two drugs in US 30 May 2008 Zydus Cadila acquires Spanish drug firm Laboratories Combix 30 May 2008 Sun Pharma warns of legal action against Taro for stalling merger 29 May 2008 Israel's Taro to terminate merger with Sun Pharmaceutical 28 May 2008 Pharma firms threaten to stop production 28 May 2008 Alnylam in $1 billion RNAi drug research deal with Japan's Takeda 28 May 2008 Ranbaxy gets partial relief in `atorvastatin' case in Australia 28 May 2008 GVK BIO enters into drug discovery pact with Wyeth Pharmaceuticals 26 May 2008 Novo Nordisk seeks approval of new Type 2 diabetes drug in US, Europe 24 May 2008 Suven Life gets product patents in South Africa, China 20 May 2008 Zydus Cadila to market four products in the US after USFDA approval 16 May 2008 GlaxoSmithKline, Daiichi in hypertension drug deal in India 14 May 2008 Intercell to acquire Iomai Corporation for $189 million 13 May 2008 Ranbaxy to develop new drugs for Merck & Co 10 May 2008 Johnson & Johnson patent lawsuit agains Boston Scientific's NIR stent dismissed in Canada 09 May 2008 Jubilant Organosys acquires Speciality Molecules for about Rs20 crore 08 May 2008 Enzon Pharma to spin off biotechnology business 08 May 2008 Novo Nordisk researchers nominated for Europe’s top innovation prize for new version of insulin 06 May 2008 GSK Pharma signs licensing agreement with Astellas of Japan 05 May 2008 Indian vultures face extinction due to diclofenac poisoning 05 May 2008 Divested from Pfizer, Esperion Therapeutics completes $22.75-million series A financing 03 May 2008 Bristol-Myers Squibb sells ConvaTec to PE firms for $4.1 billion 03 May 2008 Merck extends enrollment deadline for US Vioxx product liability lawsuit claimants 03 May 2008 Teams unravel heparin death mystery 02 May 2008 Dr Reddy's acquires BASF's contract manufacturing business in US 30 April 2008 Novartis Research announces breakthrough in restoring light sensitivity in damaged retinas 29 April 2008 US FDA turns down Merck's ER niacin / laropiprant 29 April 2008 Ranbaxy gets a boost as US patent office rejects Pfizer's Liptor plea 28 April 2008 Brazil declares anti-AIDS drug to be of public interest; India's pharma industry may benefit 28 April 2008 Pfizer forms diabetes, obesity research consortium with universities 26 April 2008 Government brings 1,421 drugs under Price Control Order 25 April 2008 GlaxoSmithKline acquires Sirtris Pharmaceuticals 24 April 2008 Delhi HC upholds ruling in Cipla-Roche cancer drug row 23 April 2008 Ranbaxy forces Orchid into an alliance 22 April 2008 Dabur Pharma to sell majority stake to Singapore-based Fresenius Kabi Pte Ltd 19 April 2008 Nicholas Piramal buys two Khandelwal Laboratories brands for Rs116 crore 16 April 2008 Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US 15 April 2008 Why Ranbaxy fancies Orchid 14 April 2008 Ranbaxy group closer to 15 per cent stake in Orchid 14 April 2008 Ranbaxy's Solrex picks up 1 per cent more in Orchid Chemicals 11 April 2008 Japan's Takeda to acquire Millennium Pharma for $8.8 billion 10 April 2008 Glenmark's Swiss arm completes Phase I trials for monoclonal antibody GBR 500 10 April 2008 Orchid Chemicals announces Japanese subsidiary 10 April 2008 Orchid Chemicals stock surges as Ranbaxy group hikes stake 08 April 2008 Ranbaxy receives Japanese authorisation for product development outside Japan 08 April 2008 Dr Reddy's acquires Jet Generici Srl; to establish generics range in Italy 03 April 2008 Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis 03 April 2008 Teva to acquire Bentley Pharmaceuticals 01 April 2008 Dr Reddy's to buy two Dowpharma Small Molecules units in the UK 01 April 2008 Indian Pharma Industry should make 40 per cent of the world's generic drugs: APJ Abdul Kalam 31 March 2008 Aurobindo acquires Italian generic pharma firm TAD 24 March 2008 Wockhardt says derivative losses not to affect Q1 performance 24 March 2008 Cipla to continue selling its version of Roche's lung cancer treatment drug 20 March 2008 Japan's biggest drug maker to expand in the US 20 March 2008 Sun Pharma gets US FDA approval to market generic Cerebyx 20 March 2008 Ranbaxy to introduce dental drug Inersan in India, Nepal 18 March 2008 USFDA approves Sun Pharmaceutical's generic cancer drug Ethyol in US markets 17 March 2008 Glenmark Pharmaceuticals launches Clobetasol from its niche dermatology pipeline 17 March 2008 SC refuses to stay Gujarat HC order on Ranbaxy's 'Volini' ad 12 March 2008 Suven Life signs another drug research pact with Eli Lilly 12 March 2008 Dr Reddy's Laboratories and 7TM Pharma sign drug research pact 10 March 2008 USFDA grants tentative approval to Sun Pharma's generic anti-cancer injection Gemzar 07 March 2008 Pfizer to acquire Serenex, extend oncology pipeline 05 March 2008 Drug Controller approves Venus Remedies' latest antibiotic drug 04 March 2008 Drugs to become cheaper: Ram Vilas Paswan 01 March 2008 Dabur launches injection for cancer treatment in US 29 February 2008 Baxter withdraws heparin blood thinners made from Chinese supplies 29 February 2008 Matrix Labs may divest Docpharma 28 February 2008 Shasun Chemicals technology licenses API technology to Merck 27 February 2008 New Novartis Research Institute first to focus on innovative vaccines for the developing world 23 February 2008 Nicholas Piramal Research in India's first public-private drug research project 22 February 2008 Sun Pharmaceutical buys Taro Pharma shares from Brandes 20 February 2008 Ranbaxy board approves de-merger of new drug discovery research unit in to Ranbaxy Life Science Research Ltd 19 February 2008 AstraZeneca forms clinical research venture with private equity firms 18 February 2008 Zydus Cadila launches new drug for cancer therapy 15 February 2008 Nicholas Piramal R&D arm in $110-million new drug deal with Eli Lilly 15 February 2008 Patent expiries destabilise global pharmaceutical majors, says Datamonitor research 14 February 2008 Wockhardt's Azithromycin to battle Pfizer's Zithromax in the US market 13 February 2008 Bayer HealthCare affiliate MEDRAD to acquire devises maker Possis Medical 12 February 2008 Strides Arcolab acquires 17.7-per cent stake in Genepharm Australasia 08 February 2008 Alpharma divests API business to 3i for $395 million 07 February 2008 Nicholas Piramal launches hypertension product 07 February 2008 USFDA grants tentative approval to Ranbaxy's esomeprazole magnesium DR capsules in the US 07 February 2008 Glenmark receives milestone payment from Forest Labs for phase II study on Oglemilat 06 February 2008 US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales 06 February 2008 DiaGenic announces preliminary results from Indian breast cancer study 05 February 2008 Amgen and Takeda announce exclusive collaboration in Japan on up to 13 Amgen clinical candidates 04 February 2008 US FDA grants tentative approval to Teva's generic Flomax capsules 01 February 2008 Sun Pharma launches generic version of Wyeth's Protonix 30 January 2008 Shasun Chemicals to set up new facilities in N. America 28 January 2008 US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant 28 January 2008 Matrix Laboratories hikes stake in China's Mchem to 97 per cent 25 January 2008 Novo Nordisk divests three metabolic-disorder treatment programmes to TransTech Pharma 25 January 2008 Anti-smoking vaccines set to help millions; to boost prescription market 25 January 2008 Zydus Cadila to collaborate with US-based Prolong Pharmaceuticals for drug discovery 24 January 2008 Roche to acquire Ventana for $89.50 per share 23 January 2008 Teva to acquire CoGenesys 23 January 2008 Nicholas Piramal buys Healthline's pharmaceuticals business 23 January 2008 Suven Life Sciences receives second US patent 23 January 2008 Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline 21 January 2008 Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis 21 January 2008 Wockhardt to demerge R&D business 18 January 2008 Pfizer-funded study reports reduction in heart attacks by adding Lipitor early to blood pressure treatment 18 January 2008 India asks Indonesia to remove non-tariff barriers on Indian pharma products 18 January 2008 WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug 14 January 2008 Ranbaxy enters Chyawanprash market with suger-free `Chyawan Active' 11 January 2008 US wants to open FDA office in India 11 January 2008 Strides Arcolab discontinues manufacturing operations in New Jersey 09 January 2008 Genzyme and Isis announce strategic alliance including exclusive worldwide license of Mipomersen 08 January 2008 Marksans Pharma acquires UK’s Hale Group Ltd, owner of Bell, Sons & Co 07 January 2008 Panacea Biotec pre-qualified by WHO to supply children's immunisation drug 05 January 2008 National Pharmaceutical Pricing Authority seeks cost data from pharmaceutical industry 04 January 2008 Cephalon seeks second use for chemo drug 03 January 2008 Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US 02 January 2008 Suven Life Sciences receives first product patent in the US 27 December 2007 Aurobindo Pharma gets US approval to sell generic Omnicef 19 December 2007 Nicholas Piramal in JV with Japan's Arkray to market blood glucose monitoring products 19 December 2007 Health minister to release Indian Pharmacopoeia 2007 17 December 2007 Novartis plans to cut 22,00 jobs worldwide 13 December 2007 Drug prices fixed under DPCO 1995 have to be compulsorily implemented: Government 11 December 2007 Nicholas Piramal's cyclin-dependent kinase inhibitors granted US product patent 11 December 2007 Eli Lilly predicts higher 2008 profit; to launch new products by 2011 07 December 2007 Bristol-Myers Squibb will cut jobs, close plants, to save $1.5 billion 07 December 2007 US FDA panel rejects the use of Genentech’s Avastin for breast cancer 07 December 2007 Sun Pharma announces settlement of litigation over generic Exelon 06 December 2007 Matrix Labs gets US FDA nod for HIV drug 05 December 2007 Abbott Labs cuts 1,200 jobs as drug-coated heart stent market shrinks 05 December 2007 French drug giant Sanofi-Aventis opens R&D centre in Goa 05 December 2007 Pfizer to outsource 30 per cent of manufacturing to Asia, cut 10,000 jobs 04 December 2007 Bristol-Myers Squibb likely to cut 4,300 jobs 01 December 2007 Astellas acquiring cancer biotech firm Agensys 27 November 2007 Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products 24 November 2007 Nicholas Piramal in R&D collaboration with Merck & Co 19 November 2007 Pfizer to acquire Coley Pharmaceutical for $164 million 19 November 2007 US FDA approval Orchid's ANDA for Cefpodoxime Proxetil 17 November 2007 Dr Reddy's gets US FDA nod for marketing Ciprofloxacin 17 November 2007 Glenmark Pharma to spin off generics unit, list new unit next year 17 November 2007 Merck agrees to settle Vioxx claims for $4.85 billion 15 November 2007 GSK to launch cancer drug Tykerb in India 10 November 2007 Contract research firm Manipal AcuNova acquires Germany''s ECRON 05 November 2007 Pfizer to license Taisho Pharmaceutical''s schizophrenia drug candidate TS-032 01 November 2007 Biocon plans Rs 100 crore annual research spend 31 October 2007 Ranbaxy wins patent case against Pfizer cholestrol drug Liptor in Germany 30 October 2007 US state Utah seeks co-operation with India in life science research 30 October 2007 Glenmark signs up marketing deal with MyerZall Labs 27 October 2007 Sigma-Aldrich, Oxford BioMedica win key ruling in Open Biosystems patent infringement dispute 26 October 2007 Glenmark and MeyerZall Laboratories to offers topical dermatology products in South Africa 25 October 2007 Suven Life Sciences, University of Minnesota to develop drugs jointly to treat HIV 25 October 2007 Ranbaxy launches Osonase nasal spray in India 25 October 2007 Wockhardt acquires US pharma firm Morton Grove Pharmaceuticals 24 October 2007 Dabur enters supply and distribution agreement with Combino Pharm 24 October 2007 US FDA approves Sun Pharmaceutical''s Novartis-equivalent generic Exelon capsules for US markets 24 October 2007 Researchers see role for `septins'' in treatment of Alzheimer''s, Parkinson''s 20 October 2007 Medical Retail chain Medicine Shoppe to expand network outside Mumbai 19 October 2007 USV in marketing tie-up with Germany''s Sebapharma 19 October 2007 Drug Controller-General approves Biocon - Abraxis BioScience breast cancer drug Abraxane 19 October 2007 Himalaya Drug Company to expand retail presence 19 October 2007 Ranbaxy follows Sun Pharma in demerging R&D business 19 October 2007 Ranbaxy plans to spin off research arm as Q3 net profit zooms 48 per cent 18 October 2007 Panjab University and Panacea Biotec to develop new chemical entities 10 October 2007 Government plans central authority for drug licensing 08 October 2007 Avesthagen-Cipla JV acquires Siegfried Biologics in Germany 05 October 2007 Accenture and Bristol-Myers Squibb launch pharmaceutical industry''s first joint centre for pharmacovigilance 14 September 2007 Toray develops Hepatitis C vaccine 28 August 2007 Matrix to acquire residual holding in China''s Mchem group 25 August 2007 No data on of siphoning of funds by pharmaceutical companies: Minister 24 August 2007 Roche secures US court injunction for its Ventana bid 23 August 2007 Boston Scientific to explores divestment of surgical products unit 18 August 2007 Ranbaxy could gain as Pfizer loses initial bid for Lipitor patent extension 17 August 2007 Ajanta Pharma out licences formulation technology to Taiwan''s Orient Europharma 16 August 2007 Ipca-Ranbaxy alliance to market Metformin HCL tablets in US 14 August 2007 Unigene Laboratories acquires exclusive licence for therapies from University of London 10 August 2007 Lupin to invest Rs200 crore in new plant, capacity addition 10 August 2007 Biocon in pact with Abraxis to market breast cancer drug Abraxane in India 09 August 2007 Switzerland not to take Novartis case before WTO 08 August 2007 Patent tussle fallout: MNCs may turn cautious on India 07 August 2007 Bayer HealthCare and Nektar Therapeutics to develop innovative therapy for pneumonia 06 August 2007 Strides Arcolab completes acquisition of Diaspa''s fermentation facility in Italy 06 August 2007 Chennai court rejects Novartis patent challenge 06 August 2007 KKR Boots' debt may devolve on underwriters 04 August 2007 Dr Reddy's and Rheoscience commence Phase III diabetes drug trials 02 August 2007 Genstar makes another grab for PRA 31 July 2007 Merck buys cardiac biotech start-up NovaCardia 31 July 2007 Ranbaxy to sell authorised generics product Isoptin SR in US 30 July 2007 Indonesia bans cosmetics, medicine and food from China 30 July 2007 Biocon enters into JV with Neopharma of UAE 30 July 2007 Genstar to acquire contract drug manufacturer PRA for second time 28 July 2007 SNC-Lavalin acquires pharma engineering firm Pipecon 27 July 2007 Merck to acquire NovaCardia for $350 million 27 July 2007 Aventis group firm acquires diabetes drug technology from Themis 26 July 2007 Ranbaxy, GSK to settle valacyclovir patent case in US 26 July 2007 Elder Pharma to acquire 20 per cent stake in UK's Neutra Health 26 July 2007 GlaxoSmithKline pharmaceuticals divests fine 26 July 2007 Significant opportunities for Ranbaxy from GlaxoSmithKline deal: Malvinder Singh 26 July 2007 Neutra Health acquisition to facilitate entry into regulated markets: Elder Pharma 26 July 2007 Nicholas Piramal''s new drug IND-P276 approved by US FDA 25 July 2007 Teleflex avquires medical products maker Arrow for $2 billion 25 July 2007 China asks tainted food and drug firms to shut down 23 July 2007 Swedish pharma firm Meda to acquire Medpointe 23 July 2007 Purdue Pharma fined $634 million for OxyContin deaths; executives punished 22 July 2007 Court revives shareholder lawsuits over Vioxx against Merck 20 July 2007 Glenmark acquires rights to two therapeutic antibodies from Chromos 19 July 2007 Abraxis BioScience to license biosynthetic cancer drug from Biocon 19 July 2007 Lupin gets DCGI nod for phase II and III clinical trials of herbal psoriasis drug 19 July 2007 Orchid Chem to launch three new products in the US 18 July 2007 World Bank blacklist two Indian pharma companies for ''collusive'' practices 17 July 2007 Rebuffed by Ventana, Roche may increase its $3-billion bid 13 July 2007 Dishman Pharma to acquire Solvay's Dutch fine chemicals unit 09 July 2007 Novartis AG receives first worldwide approval in US for Alzheimer''s patch 09 July 2007 Roche goes to court over Ventana''s poison-pill defence 05 July 2007 Roche makes hostile offer for Ventana 27 June 2007 Roche buys Toyama''s arthritis drug for $370 million 26 June 2007 Ranbaxy to benefit from 180-day US market exclusivity for its pravastatin 25 June 2007 Zydus Cadila acquires Brazilian company Nikkho 25 June 2007 China slaps anti-dumping duty on antibiotic from India 16 June 2007 US panel blocks Sanofi''s weight-loss drug 16 June 2007 Dr Reddy's commences operations in Nigeria 16 June 2007 Rising disease may take India to top 10 pharma markets by 2020 13 June 2007 Aurobindo Pharma rules out stake sale 13 June 2007 Strides Arcolab acquires Grandix for Rs100 cr 12 June 2007 Nicholas Piramal in tie-up for cancer, diabetes research 11 June 2007 Nigeria sues Pfizer for illegal drug trials, claims $7 billion in damages 05 June 2007 Strides Arcolab to buy Italian Diaspa''s drug unit 29 May 2007 Ranbaxy buys 13 dermatology brands from Bristol-Myers 28 May 2007 Alembic enters into licensing pact with Belgian co 24 May 2007 Indian pharma to grow big in few years 24 May 2007 NPPA strikes drug firms for raising MRP 24 May 2007 Sun Pharmaceutical to acquire Taro Pharma for $454 million 21 May 2007 Lupin receives tentative US FDA approval for anti-psychotic drug Ziprasidone 21 May 2007 Dr Reddy's is setting up two SEZs 19 May 2007 Glenmark receives US FDA approval for cardiac and NSAIDs generics 16 May 2007 Mylan Laboratories to acquire Merck generics unit for $6.6 billion 14 May 2007 FDA panel seeks curbs on Amgen, J&J anaemia drugs 11 May 2007 FDA fines US drug firm $634m over painkiller misleads 11 May 2007 Dabur Pharma sets up US subsidiary 09 May 2007 Wockhardt acquires France`s Negma Labs for Rs1,090 crore 03 May 2007 Internal accruals to fund Negma acquisition: Khorakiwala 03 May 2007 AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion 28 April 2007 Jubilant Organosys acquires Hollister-Stier of US for $122.5 million 26 April 2007 KKR-Pessina combine to buy Alliance Boots for $22.2 billion 25 April 2007 US FDA approves Ranbaxy''s pravastatin sodium tablets 25 April 2007 Wockhardt to launch Italy''s B-Lift range of dermatology products in India 23 April 2007 Zydus Cadila acquires Nippon Universal of Japan 19 April 2007 19 April 2007 Wockhardt to introduce treatment for dermatological scars 17 April 2007 Nestle to acquire Gerber for $5.5 billion; eyes US expansion 12 April 2007 Lupin gets USFDA approval for paediatric Suprax oral suspension 12 April 2007 Bidding battle expected for Boots 10 April 2007 Government warns Novartis of compulsory licensing 10 April 2007 Orchid enters Canadian market with two generic formulations 10 April 2007 Ranbaxy Labs acquires 14.9-per cent stake in Jupiter Bio Science 07 April 2007 Lupin sells part rights of 'perindopril' to French firm for Rs115 crore 07 April 2007 India court reserves order in Novartis patent case 05 April 2007 Terapia Ranbaxy receives 3-year GMP certification renewal for Bucharest facility 04 April 2007 Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007 Eli Lilly sues Sun Pharma over patent for cancer drug 02 April 2007 Novartis slumps after pulling Zelnorm 31 March 2007 Alliance Boots gets revised $20 billion offer from KKR, Pessina 31 March 2007 Ranbaxy launches asthma drug 'Osovair' in India 30 March 2007 Strides Arcolab gets tentative US FDA nod for AIDS drug 29 March 2007 Glenmark confirms filing ANDA with ''paragraph IV certification'' for Zetia tablets 28 March 2007 Wockhardt receives US FDA approval for diuretic injection 28 March 2007 Government to enforce 5-per cent cut in prices of 75 drugs 27 March 2007 Glenmark acquires Czech firm Medicamanta 26 March 2007 Is Torrent a serious contender for Merck? 23 March 2007 Opportunities for India in generic drug space 21 March 2007 Ranbaxy withdraws bid for Merck's generic business 20 March 2007 Zydus Cadila acquires Liva Healthcare 17 March 2007 Ranbaxy enters second round of bidding for Merck unit: report 16 March 2007 Ranbaxy gets USFDA nod for zolpidem tablet production in US 16 March 2007 Biocon arm to set up dedicated R&D facility for Bristol-Myers Squibb 14 March 2007 Strides Arcolab receives US FDA approvals for two new drugs 14 March 2007 Boots rejects KKR's £9.7 billion offer as being low 13 March 2007 Lupin gets marketing approval for cefpodoxime proxetil in France 13 March 2007 Akzo Nobel sells Organon BioSciences to Schering-Plough for €11 billion 13 March 2007 Ranbaxy Laboratories Bids for Merck''s Generic Unit 13 March 2007 Merck suffers adverse Vioxx lawsuit in the US 13 March 2007 Boots to consider KKR's £9.7 billion offer 12 March 2007 Glenmark in funded research agreement with Swiss firm Dyax 12 March 2007 After acquiring Schering, Bayer to cut 6,100 jobs worldwide 03 March 2007 US firm acquires global rights for anti-cholestrol drug from Ranbaxy 01 March 2007 Ranbaxy plans ADS offering to finance Merck arm acquisition 21 February 2007 Biocon to invest Rs 1,000 crore in Vizag SEZ 17 February 2007 ADAG to rewrite drug distribution rules 10 February 2007 Ranbaxy enters biosimilar product space with Zenotech, targets EU markets 08 February 2007 Ranbaxy-Glaxo extend pact 07 February 2007 Pfizer loses battle for Chinese name for Viagra 06 February 2007 Dr Reddy's to join the race for Merck's generic business 05 February 2007 Glaxo moves court against Ranbaxy''s generic drug 03 February 2007 Wyeth sued over Zosyn patent 03 February 2007 Global collaboration to develop new anti-obesity compounds 02 February 2007 Pfizer wins Norvasc patent case against Synthon 02 February 2007 Ranbaxy launches two NDDS Urology products in India 30 January 2007 Novartis patent case a threat to developing nations: Medecins Sans Frontieres 30 January 2007 Sun Pharma to acquire companies in the US 24 January 2007 Pfizer to retrench 8,000 22 January 2007 US move to prevent restrictions on generic drugs 18 January 2007 Biocon grants marketing license for cancer drug in Pakistan 18 January 2007 Ranbaxy pitted against Texas Pacific, Cinven, Permira for Merck''s generic-drug unit 12 January 2007 Organon Biosciences in biopharma development deal with China's Huya Bioscience 10 January 2007 Mylan completes stake acquisition in Matrix 10 January 2007 Ranbaxy to bid over $5 billion for Merck Generics 09 January 2007 Suven Life Sciences Secures Patent 09 January 2007 Only 12 per cent of drugs market to be under price control 08 January 2007 Biocon in joint venture with Abu Dhabi-based Neopharma 06 January 2007 Chemists body in TN plans distribution firm 05 January 2007 Dabur launches new delivery system for anti-cancer drug 04 January 2007 Ipca - Ranbaxy alliance receive US FDA marketing approval for atenolol tablets 02 January 2007 Lupin awarded tentative US FDA approval for sertraline 02 January 2007 Aurobindo Pharma acquires Dutch company 30 December 2006 Ipca's 'Atenolol' bulk drug registered in China 29 December 2006 Wockhardt, Dr Reddy's launch generic Ondansetron in the US 27 December 2006 Biocon subsidiary Clinigene completes phase-IV study on new generation insulin 26 December 2006 Iceland''s Actavis acquires manufacturing plant in Chennai 22 December 2006 Aurobindo receives approval for AIDS drug 22 December 2006 Reliance Life Sciences to acquire UK's GeneMedix 22 December 2006 Why is RLS interested in GeneMedix? 22 December 2006 Ranbaxy wins Lipitor patent against Pfizer in Australia 21 December 2006 Eli Lilly accused of concealing health risks of Zyprexa 19 December 2006 Glaxo buys Genmab's leukemia drug for record $2.1 billion 19 December 2006 Ranbaxy, department of science and technology to jointly develop new drugs 18 December 2006 Ayurvedic mouthwash to relieve radiation pain in cancer patients 16 December 2006 Nestle acquires Novartis nutrition food unit for $2.5 billion 15 December 2006 Ranbaxy gets USFDA approval for Cefprozil anti-infective tablets 15 December 2006 Glenmark to start clinical trials of painkiller in Europe 14 December 2006 J&J's acquisition of Pfizer Healthcare passes anti monopoly scrutiny 13 December 2006 Forest''s Lexapro tops anti-depresant drug trial 08 December 2006 Akorn-Strides JV takes product pipeline to 29 ANDAs 07 December 2006 Dabur Pharma gets US FDA approval for cancer drug 07 December 2006 Glenmark signs an additional deal for seven ANDAs with LVT 07 December 2006 Panacea signs joint venture pact with Cambridge Biostability of UK 06 December 2006 Pfizer aborts cholesterol drug tests 04 December 2006 Ranbaxy acquires South Africa's fifth largest generics company 01 December 2006 Dr Reddy's to raise Rs 1,027 crore through additional ADS issue 30 November 2006 Torrent in pact with DRL to market Listril and Listril Plus in Russia 29 November 2006 FDA orders withdrawal of Wockhardt's insulin brand 'Wosulin' 25 November 2006 Nicholas Piramal signs collaboration pact with BioSyntech 17 November 2006 Glenmark develops API for Napo''s phase III diarrhoea drug trials by US 17 November 2006 Tata Group''s Advinus to develop metabolic drugs for Merck 16 November 2006 US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s 15 November 2006 Zydus Cadila files novel drug candidate for obesity disorders 14 November 2006 Abbott''s Kos acquisition driven by growth in cholesterol market 09 November 2006 Merieux Alliance acquires majority stake in Shantha Biotechnics 09 November 2006 Panacea Biotec's R&D centre gets government recognition 07 November 2006 Drug makers turn from blockbusters to ''niche-busters'' for future growth 03 November 2006 Government reduces dealer margins on 886 medicines 31 October 2006 Orchid to help Swedish drug major in drug research 30 October 2006 Nicholas Piramal signs R&D licensing agreements with UK''s Morvus Technology 27 October 2006 Ranbaxy to introduce Debiopharm's gastro drug in India 23 October 2006 New Drugs Act: What''s in store for Indian drug industry? 19 October 2006 Claris Life Sciences to expand capacity and product portfolio 13 October 2006 Granules India forms joint venture with Chinese company 12 October 2006 Step towards full backward integration with supply chain says Granules MD 12 October 2006 Torrent signs in-licensing deal to market Chinese cardiac blockbuster 11 October 2006 Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row 10 October 2006 IPCA phases out single ingredient malarial drug; launches India's first ACT 06 October 2006 Pfizer still biggest player in highly prized indication: Datamonitor 06 October 2006 US FDA approves Aurobindo Pharma''s Meloxicam for US sales 06 October 2006 Wockhardt acquires Pinewood for $150 million, fourth European acquisition 03 October 2006 Nicholas Piramal acquires Boots Piramal Healthcare 03 October 2006 Dr Reddy’s, ClinTec International announce co-development of anti-cancer compound 28 September 2006 Dr Reddy's opens manufacturing facility at Visakhapatnam 26 September 2006 Sterling Bio to acquire gelatin company in China 26 September 2006 JB Chemicals, Matrix Labs in licensing agreement with Gilead Sciences for HIV drug 22 September 2006 Germany''s Merck acquires Europe''s largest biotech company 21 September 2006 Orchid's formulation and API facilities approved by UK MHRA 21 September 2006 Ipca Laboratories in marketing alliance with Ranbaxy for US sales 21 September 2006 US FDA approves Ranbaxy's sale of furosemide in the US 21 September 2006 German Remedies launches third-generation inhaler for asthamatics 20 September 2006 Biocon launches cancer anti-body drug BioMab-EGFR 18 September 2006 Ranbaxy to market Ethypharm's cardiovascular drug in India 18 September 2006 Fifth volume of Ayurveda Pharmacopoeia released 18 September 2006 Dr Reddy's acquires Spain's Litaphar: CNBC 18 September 2006 Wockhardt to develop SEZ near Aurangabad for its global biopharma hub 18 September 2006 Is pharma retailing the next big opportunity? 13 September 2006 Wockhardt close to acquiring Pinewood: CNBC 13 September 2006 Ranbaxy receives US FDA nod to market loperamide hydrochloride and simethicone tablets 11 September 2006 Government to grant limited period protection for new drugs 05 September 2006 Biocon's Syngene International and Sweden's Innate Pharma to develop virulence blockers 04 September 2006 Strides Arcolab to acquire drug unit in Singapore 01 September 2006 Wockhardt's Cefotaxime injection receives US FDA approval 31 August 2006 India to host Asia biotech meet 30 August 2006 Ranbaxy wins two additional atorvastatin patents in Norway 30 August 2006 Aurobindo betalactum facility receives MCC South Africa's approval 28 August 2006 Update: Generic API biz to strengthen post deal says Matrix Labs CEO 28 August 2006 Mylan Labs to acquire Matrix Labs for $736 million 28 August 2006 Mid Pharma looks outside itself to drive revenue: Datamonitor 26 August 2006 TAKE Solutions wins Dabur Pharma order 24 August 2006 Dishman Pharmaceuticals acquires Carbogen AMC1S from Solutia 23 August 2006 GSK withdraws patent plea for AIDS drug Combivir 21 August 2006 Unbranded drugs may get cheaper by 50-60 per cent 18 August 2006 Aurobindo gets marketing approval for mirtazapine tablets in UK 18 August 2006 Expect Tazobactum approval by June 07: Orchid Chem 16 August 2006 Suven completes pre-clinical trials of new drug molecule 16 August 2006 Aurobindo gets second MHRA approval in UK for mirtazapine tablets 09 August 2006 Panacea Biotec granted patent for 'controlled release' nimesulide composition 07 August 2006 Ranbaxy receives tentative US FDA approval to market Risperidone oral solution 05 August 2006 Glenmark gets DCGI nod for Phase II trials of diarrhoea drug 03 August 2006 Mixed victory for Ranbaxy in patent row with Pfizer 03 August 2006 Orchid to acquire 100 per cent in US drug discovery unit Bexel 01 August 2006 Orchid Chemicals hosts presidential visit at its formulations complex 31 July 2006 Hope to maintain margins at 15 per cent: JB Chemicals 29 July 2006 US FDA approves drug to treat rare genetic disease 25 July 2006 Lupin gets US FDA approval for Meloxicam 20 July 2006 Gates Foundation to fund collaborative research for HIV vaccine 20 July 2006 Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain 18 July 2006 ReAble to acquire DJO for $1.6 billion 18 July 2006 Panacea opens new Baddi facility and office in Mumbai 17 July 2006 Glenmark, Merck''s Generics in derma products pact in the UK 17 July 2006 Panacea to market PT Bio's measles vaccine 12 July 2006 Aurobindo receives US FDA approval for 3-in-1 ARV combination 03 July 2006 Welspun acquires UK''s top towel brand, Christy 03 July 2006 New Genentech eye drug gets FDA approval 01 July 2006 Ranbaxy's 'Cefprozil' gets US FDA approval 01 July 2006 Bayer divests diagnostics to Siemens, eases impact of Schering acquisition 30 June 2006 Wockhardt acquires Dumex with Protinex, Farex brands from Royal Numico NV 30 June 2006 GE ties up with Manipal Hospital for clinical trials 29 June 2006 U K appeals court affirms HC ruling in Ranbaxy-Pfizer case 28 June 2006 J&J to acquire Pfizer Consumer Healthcare for $16.6 billion 26 June 2006 Wockhardt UK expanding Byetta manufacturing capacity 16 June 2006 Nicholas Piramal to acquire Pfizer''s UK Facility 15 June 2006 Croatian drug firm Pliva opens research facility in India 14 June 2006 Wockhardt gets US FDA approval for anti-epilepsy drug 14 June 2006 Merck & Co develops new diabetes drug 14 June 2006 Paul Royalty to finance drug development by Glenmark 05 June 2006 Wockhardt in-licenses dermatology drug from LSI of UK 05 June 2006 Wockhardt receives US FDA approval for clarithromycin tablets 01 June 2006 Zydus Cadila receives US FDA approval to market Warfarin in the US 01 June 2006 Lupin to acquire 51-per cent stake in Dafra 25 May 2006 Dishman to acquire Solutia's pharmaceutical services business 24 May 2006 Lupin gets US FDA approval for Cefdinir 24 May 2006 Dr Reddy's launches oral bronchodilator for asthma, COPD 16 May 2006 US FDA approves Wockhardt's Waluj plant 11 May 2006 Roche reports strong global sales for Tamiflu 27 April 2006 Biocon Biopharmaceuticals’ new biologics facility 17 April 2006 Dr Reddy's receives US FDA approval for fexofenadine hydrochloride 13 April 2006 Pharmacies gear-up to ride the retail boom 12 April 2006 Glenmark, is India''s first pharma company to implement ''structured product labeling'' 31 March 2006 Pfizer India Q1 net jumps 84 per cent 29 March 2006 Ranbaxy to acquire Glaxo's generic business in Italy 28 March 2006 Ind Swift Laboratories API facility gets TGA certification 22 March 2006 Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation 22 March 2006 Ranbaxy acquires patent & rights for auto-injector device 21 March 2006 Zydus Cadila to commence phase II clinical trials on ZYH1 20 March 2006 Bristol-Myers grants ARV license for two drugs to Aurobindo Pharma 17 March 2006 Aurobindo receives first NDA approval for HIV-1 drug from US FDA 16 March 2006 Update: US FDA nod for Aurobindo''s Lisinopril & Hydrochlorothiazide tabs 16 March 2006 Ranbaxy Laboratories ties-up with Zenotech to market cancer injectibles 09 March 2006 Aurobindo Pharma receives final US FDA approval for Mirtazapine ODT 45mg 02 March 2006 Wockhardt receives US FDA approval for Ranitidine OTC version 27 February 2006 Setback for Ranbaxy; Finnish court reverses earlier verdict on Lipitor 22 February 2006 Merck wins second Vioxx lawsuit 18 February 2006 Ranbaxy raises $400 million from FCCB issue 16 February 2006 Glenmark Pharmaceuticals announces new drug discovery for obesity 13 February 2006 Glenmark Pharmaceuticals Clinical Research unit in India receives ANVISA approval 08 February 2006 Ranbaxy forms South African JV to sell AIDS drug 06 February 2006 Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm 03 February 2006 Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs 02 February 2006 Dr Reddy's Laboratories enters into agreement with Merck 01 February 2006 Natco Pharma acquires 75 per cent in US retail store 31 January 2006 Boston Scientific beats J&J to acquire Guidant for $27 billion 25 January 2006 Aurobindo receives UK MHRA approval 20 January 2006 Strides Arcolab signs partnership with The Clinton Foundation for HIV Drugs 13 January 2006 Ranbaxy in co-marketing agreement with Ferring of Switzerland 10 January 2006 Dishman Pharmaceuticals clarifies news item 06 January 2006 Shasun Chemicals signs LoI with to acquire plants, processes, patents of French firm 06 January 2006 JB Chemicals, Taro Pharmaceutical in product development agreement 05 January 2006 Glenmark Pharmaceuticals acquires Bouwer Bartlett, South Africa 26 December 2005 Wockhardt amongst first to receive US FDA approval for Zonisamide Capsules 26 December 2005 Roche grants Tamiflu licence to Hyderabad firm Hetero Drugs 24 December 2005 US FDA grants tentative approval to Aurobindo''s anti-AIDS drug for children 23 December 2005 Merck, ICMR to conduct joint trials on cervical cancer vaccine 22 December 2005 Ranbaxy, Cephalon to settle Provigil patent litigation 22 December 2005 JB Chemicals to set-up wholly owned subsidiary in Russia 21 December 2005 Dishman Pharmaceuticals acquires IO3S, Switzerland 20 December 2005 Natco Pharma finalises terms for supply of two onco formulations 20 December 2005 US FDA approves Lupin's cefprozil suspension, Orchid's tablets 20 December 2005 Ranbaxy to appeal US District Court decision upholding Pfizer Atorvastatin Patents 19 December 2005 TCS to provide end-to-end clinical trial data management solution for Novo Nordisk 19 December 2005 Zydus Cadila to set up JV with Bharat Serum; files second IND 16 December 2005 Glenmark Pharmaceuticals, InvaGen Pharmaceuticals in marketing tie-up 15 December 2005 Aurobindo Pharma selected for IDMA''s patents appreciation award. 15 December 2005 Final US FDA approval for Aurobindo''s Mirtazapine oral disintegrating tablets 14 December 2005 Aurobindo Pharma''s anti-AIDS drug selected by WHO 12 December 2005 Natco Pharma receives Patent Appreciation Award 12 December 2005 Transgene Biotek develops oral vaccines for diabetes and Hepatitis B 07 December 2005 Ranbaxy offers to help U S combat avian flu 02 December 2005 Orchid Chemicals hosts presidential visit at its formulations complex 02 December 2005 New Indo-UK JV company to recruit patients for drug trials 01 December 2005 Lupin receives US FDA approval for Cephalexin capsules 01 December 2005 Tentative US FDA approval for Zydus Cadila's gatifloxacin tablets 29 November 2005 Government to set up separate pricing models for different drug categories 28 November 2005 Ranbaxy honours scientists for outstanding research 28 November 2005 Lupin receives IND approval from DCGI for Desoris LLL-3348 28 November 2005 Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement 24 November 2005 US Court of Appeals upholds preliminary injunction against Ranbaxy 23 November 2005 AstraZeneca sues Ranbaxy on Nexium patent 22 November 2005 Zydus Cadila receives approval for Sertraline from AFSSAPS, France 22 November 2005 Ranbaxy scores over Pfizer in Norwegian court over cholesterol drug 10 November 2005 Orchid Chemicals' fire victims were insured: K Raghavendra Rao 08 November 2005 Dr Reddy''s to acquire Roche business in Mexico 08 November 2005 Venkat Pharma secures $400,000-US order for dietary supplements 02 November 2005 AstraZeneca and Nicholas Piramal sign ''development and know-how'' agreement 27 October 2005 Nicholas Piramal acquires UK''s Avecia for £9.5 million 27 October 2005 CRISIL reaffirms Ranbaxy''s outstanding ratings despite court ruling 15 October 2005 Glenmark Pharmaceuticals targets GPs 10 October 2005 Orchid, AstraZenwca, receive Frost and Sullivan pharma awards 03 October 2005 Zydus Cadila receives tentative US FDA approval for Ribavirin tablets 03 October 2005 Aurobindo receives approval for sertraline hydrochloride tablets 27 September 2005 Unichem Laboratories to step up R&D from Bangalore 23 September 2005 Matrix acquires 43 per cent stake in Swiss firm Explora Labs 21 September 2005 Pharma sector to top Rs.60,000 crore by ''08 21 September 2005 NPPA revises 16 bulk drug prices 20 September 2005 Government evaluating ''data exclusivity'' demand of pharma companies 17 September 2005 Eisai becomes first Japanese pharma firm to enter India 17 September 2005 Ranbaxy obtains US FDA approval for high BP drug 14 September 2005 Shanta Biotechnics launches 4-in-1 combination vaccine 20 August 2005 Eli Lilly launches anti-diabetes drug variant 11 August 2005 Sun Pharma to buy manufacturing site in Hungary 11 August 2005 Wockhardt becomes only pharmaceutical Superbrand in India 20 July 2005 Wockhardt joins $billion league 20 July 2005 Aurobindo Pharma plans to raise funds from global markets 06 July 2005 Ranbaxy, JB Chem to market Doktor Mom brand in Romania 06 July 2005 Maharashtra FDA questions claims of nutraceuticals 28 June 2005 Matrix Labs acquires Belgian drug firm Docpharma for $263 m 20 June 2005 German Remedies launches anti Leukaemia drug 09 June 2005 Nectar Lifesciences to come out with Rs100cr IPO 07 June 2005 Kopran to shift focus to global markets 06 June 2005 Zydus Cadila commences phase I clinical trials on ZYH1 03 June 2005 USFDA gives tentative nod for Ranbaxy drug 01 June 2005 Zydus in JV with Australia's Mayne to manufacture oncology products in India 19 May 2005 Diovan receives EU approval for the treatment of heart attack survivors 10 May 2005 HCL Tech and IIT Delhi to work on new drugs 04 May 2005 Shantha Biotech introduces "JENCEVAC" vaccine to combat fatal brain fever 18 April 2005 Quintiles expands India operations with new clinical data management services 12 April 2005 Johnson & Johnson launches the stent war 29 March 2005 Glenmark acquires another brand in Brazil 18 March 2005 Patent Bill to be introduced next week 17 March 2005 Orchid in deal with Stada for generic drug products 17 March 2005 Mexican mission woos Indian drug majors 16 March 2005 GSK India announces buyback 15 March 2005 On the clinical trial trail 11 March 2005 Zydus ties up Mallinckrodt to market generics in USA 10 March 2005 GlaxoSmithKline to locate first Indian vaccine plant at Nashik 23 February 2005 Global pharmaceutical firms plan investments in India 19 February 2005 Nicholas Piramal signs seven alliances 19 February 2005 GlaxoSmithKline Q4-05 up at 61.4% 17 February 2005 Wockhardt launches India''s first automatic insulin delivery device and recombinant insulin cartridge 17 February 2005 The rest didn''t do badly, either 16 February 2005 Dr Reddy''s cardio drug candidate undergoing clinical trials 09 February 2005 Zydus Cadila files its first IND application for new molecule 09 February 2005 InnoCentive signs MoU with IICT, Hyderabad 04 February 2005 Pharma, IT to benefit from patents: Evalueserve 04 February 2005 Zydus Cadila receives US FDA approvals for Clindamycin 01 February 2005 Ranbaxy makes three fresh ARV filings to WHO 25 January 2005 Shantha Bio launches DNA Erythropoietin 24 January 2005 Ranbaxy Top brass reshuffled 22 January 2005 Dr Mahendra Patel joins Zydus Pharmaceuticals 20 January 2005 Ranbaxy Q4 results disappoints 19 January 2005 Zydus Cadila to host second international symposium on genomics and proteomics 14 January 2005 Shantha Biotech Introduces Shanvac-B in BD UnijectT 10 January 2005 New Year rings in new patents regime for pharma cos 01 January 2005 Nicholas Piramal to take over UK''s Rhodia 18 December 2004 Zydus and Mayne (Australia) sign MoU for JV in India 13 December 2004 Bonanza ahead for generic drug majors 09 December 2004 Sun Pharma to issue $75 million FCCB 06 December 2004 Pankaj Patel declared 'best pharma man of the year' by FIIE 01 December 2004 Sun Pharma launches $225 million FCCB 19 November 2004 Paswan caps drug prices 18 November 2004 Ranbaxy withdraws its antiretroviral''s from WHO list 10 November 2004 Stronger performance from Shasun Chemicals and Drugs Limited 18 October 2004 CII pharma summit for ''India pharma Inc'' 13 October 2004 Hanmer & Partners acquires Doc Asia 27 August 2004 Nicholas Piramal finalises product in-licensing agreement with Ethypharm, France 18 August 2004 Fortis to invest over Rs1,100 crore in integrated healthcare delivery system 17 August 2004 Nicholas Piramal in research collaboration with National Institute of Immunology 12 August 2004 Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market 11 August 2004 Dishman Pharma setting up new R&D facility 11 August 2004 Professionals take over 06 August 2004 Sun Pharmaceuticals proposes share swap with Phlox Pharma 03 August 2004 Ranbaxy net down six per cent 02 August 2004 Orchid registers turnover of Rs173.86 crore for Q1 FY 2004-05 31 July 2004 Charak Pharma in joint venture with IL&FS Investmart 23 July 2004 Acer and TVS Electronics enable sales force automation for Dr Reddy's Laboratories 20 July 2004 India emerges as global hub for pharma outsourcing 12 July 2004 Jagsonpal spreads its wings 10 July 2004 Pen G industry demands a strong shot 01 July 2004 Natco Pharma unveils new drug 26 June 2004 Medicine Shoppe to double number of outlets this fiscal 25 June 2004 Biological E to launch hepatitis-B vaccine `Bevac` in three months 16 June 2004 Jagsonpal amongst India's top fifty pharma companies 16 June 2004 Cadila eyes overseas growth opportunities 09 June 2004 FIIs pull out of Dr Reddy''s Laboratories 31 May 2004 Krebs to diversify 31 May 2004 Interview with Sandoz GmbH CEO Christian Seiwald 31 May 2004 Orchid in tie up with Par Pharmaceuticals Inc. to market oral cephalosporin in the US 28 May 2004 Sun Pharma plants get US regulatory clearance 28 May 2004 Two Sun Pharma units gets USFDA approval 27 May 2004 Granules India gets USFDA nod 24 May 2004 Orchid's US discovery JV successful 22 May 2004 Ipca launches India's first novel injectible antibiotic combination 20 May 2004 Orchid files ANDA for Cefazolin finished dosage form 15 May 2004 Templeton Strategic acquires 2.9 per cent stake in Aurobindo Pharma 08 May 2004 Dr Reddy''s acquires US company Trigenesis 07 May 2004 Wockhardt acquires German firm Esparma 07 May 2004 Sanofi India's fortune looking up 05 May 2004 03 May 2004 Jagsonpal Pharma net rises 227 per cent 03 May 2004 Ranbaxy in pact for new drug discovery 30 April 2004 Novartis launches development centre in Mumbai 28 April 2004 Zydus Cadila reports highest ever sales, net profits up 87 per cent 27 April 2004 Global pharma eyes India as BPO hub 26 April 2004 Orchid's net profit rises 59 per cent on Rs 713 crore turnover during '03 -'04 26 April 2004 1:1 bonus from Sun Pharma 24 April 2004 Maxfair Drugs launches ayurvedic formulations in Kerala 24 April 2004 Suven Life Sciences institutes scientific advisory board for CNS research 13 April 2004 Orchid Pharma soon to file ANDA from its new plant 13 April 2004 Orchid Pharma soon to file ANDA from its new plant 02 April 2004 Zydus Cadila gears up for the US market 02 April 2004 Shreya launches new generation ''Viagra'' variant 01 April 2004 Nicholas Piramal, Indian Institute of Science to develop anti-fungal drugs 31 March 2004 Orchid granted Certificate of Suitability for Cefadroxil Monohydrate 30 March 2004 Proalgen Biotech to expand operations 29 March 2004 Dishman IPO price band finalised 25 March 2004 Nicholas Piramal expands its Clinical Research facility 24 March 2004 Orchid to raise USD 75 million through FCCBs 20 March 2004 GlaxoSmithKline, Burroughs Wellcome boards approve merger 18 March 2004 Zydus Cadila launches Nucoxia 17 March 2004 Sun Pharma increases holding in Caraco 16 March 2004 Matrix Labs gets US approval for second unit 13 March 2004 Ranbaxy crosses the billion dollar mark 11 March 2004 Morepen gets USFDA approval for API manufacturing 09 March 2004 US reinsurers wary of Indian pharma firms 09 March 2004 Product patents a major issue at Bio Asia 01 March 2004 Pfizer recalls liquid Gelusil 28 February 2004 One more CoS for Orchid Chemicals 19 February 2004 Pharmexcil to be headquartered in Hyderabad 10 February 2004 Sun Pharma to increase holdings in Caraco to 60 per cent 09 February 2004 Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd. 07 February 2004 Nicholas Piramal Q3 growth up 76.1 per cent 07 February 2004 Sun Pharma logs healthy growth 03 February 2004 Ranbaxy enters the field of herbal medicine 22 January 2004 HAL and RCF divestment gains momentum 19 January 2004 Orchid posts good Q3 performance 16 January 2004 USFDA approval for Ranbaxy drug 10 January 2004 Nicholas Piramal, SPPL debt programmes reaffirmed A1+ 06 January 2004 Vera Laboratories to come out with a preferential issue 02 January 2004 Orchid Aurangabad facility bags ISO 14001, OHSAS 18001 31 December 2003 Divi''s, Matrix scrip prices cross leading pharma firms'' prices 29 December 2003 Retreat of a titan 29 December 2003 Nicholas Piramal buys partner''s 50% stake in Sarabhai Piramal 26 December 2003 Indian pharmaceutical majors oppose EMR granted to Novartis 23 December 2003 Pfizer India plans to put three manufacturing units on block 22 December 2003 European approval for Orchid Chemical's drug 18 December 2003 Ranbaxy''s first round of talks to acquire RPG Life Sciences over 05 December 2003 USFDA approval for Orchid 05 December 2003 WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets 04 December 2003 Bexel to conduct human trials 03 December 2003 Nicholas Piramal enters into alliance with Biogen Idec, USA 02 December 2003 Torrent to increase presence, set up export base in Germany 22 November 2003 Novo Nordisk unveils 2 insulin 10 November 2003 Orchid income at Rs 162 crore 04 November 2003 Bilcare net profit rises 55% 21 October 2003 FIIs hike stake in Lupin, Cadila Healthcare, Aurobindo Pharma 20 October 2003 Zydus Cadila Q2 net rises 30% 20 October 2003 Lupin to restructure board; to licence out new chemical entity 13 October 2003 Hikal gets ICRA''s A1+ rating for short-term debt programme 10 October 2003 Bilcare bags OPPI award for best packaging material in 2003 08 October 2003 Glenmark Pharmaceuticals plans major foray into US markets 08 October 2003 Orchid Pharma's API facilities inspected by EDQM, MHRA UK 06 October 2003 Caraco Pharma gets USFDA nod for tizanidine hydrochloride 03 October 2003 Nicholas Piramal follows MNC pharma companies'' strategy 03 October 2003 Nicholas Piramal rolls out growth plan; Maini, Chaudhuri on board 03 October 2003 Zydus Cadila becomes a partner of choice for Schering AG 03 October 2003 Cadila plans major foray into generics market in US, Europe 30 September 2003 In the giving phase of life 25 September 2003 Kopran may rope in strategic financial partner for recast plan 24 September 2003 Unichem Laboratories to set up formulations facility in Himachal 24 September 2003 Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh 22 September 2003 Meet brings to fore opportunities in European pharma industry 22 September 2003 SC order to expedite pending merger of Pharmacia with Pfizer 22 September 2003 Orchid JV manufacturing facility in China commissioned 20 September 2003 Cipla eyes formulations exports to attain Rs 17-billion turnover 15 September 2003 Human touch for humanity 05 September 2003 Jitendra N Doshi to be interim chief of Caraco Pharmaceuticals 30 August 2003 Mumbai to host Global Pharma Business Convention soon 23 August 2003 Hikal''s main focus : Pharma 09 August 2003 Orchid's API and formulation facilities receive TGA approval 01 August 2003 Aurobindo Pharma to invest Rs 50 crore for R&D centre in Mumbai 29 July 2003 Sun Pharma Q1 net, sales rise 28 July 2003 Orchid Chem Q1 profits up 25 July 2003 FIIs, banks up holdings in Ranbaxy, Dr Reddy''s, Nicholas Piramal, Cipla 21 July 2003 In the pink of health 21 July 2003 Double (dis)advantage 16 July 2003 Cadila Healthcare sales up 16.1% 15 July 2003 Hikal declares bonus share of 1 : 2 14 July 2003 Lupin promoter D B Gupta to sell 12.5% stake to Newbridge 10 July 2003 Wockhardt buys CP Pharma 10 July 2003 Ind-Swift Labs net up 25% in FY 2002-03, 50% in last quarter 01 July 2003 Orchid's US drug discovery JV progresses well on BLX 1002 01 July 2003 Bombay HC okays merger of German Remedies with Cadila 28 June 2003 There is no plan to sell Vitamin B12 business, says Wockhardt 24 June 2003 Orchid, Apotex in exclusive pact to sell injectable antibiotics in US 03 June 2003 Suven Pharma acquires assets of NJ-based Synthon Chiragenics 20 May 2003 Citigroup to finalise Rs 300-cr equity investment deal in Lupin 09 May 2003 Pharma MNCs to tap Indian market post-patent regime 09 May 2003 Sun Pharma to invest Rs 25 cr in Jammu; posts good results 05 May 2003 Zydus Cadila's net profit zooms by 27% 03 May 2003 Orchid registers Rs 541-crore turnover; posts 27% growth 02 May 2003 MNC and Indian companies in race to acquire Paras Pharma 29 April 2003 Kee Pharma offers Melagenina Plus for vitiligo patients 24 April 2003 BIFR issues show-cause notice to wind up Sol Pharmaceuticals 19 April 2003 Access to medicines 17 April 2003 Morepen defaults on FDs; hit by slump in Loratadine prices 17 April 2003 Elder, Ajanta, Glenmark may buy known therapeutic brands 11 April 2003 Indian pharma sector on path to prepare for global collaboration 24 March 2003 VAT may push prices of drugs, manufacturing goods by 5% 17 March 2003 Domestic Viagra market to sizzle as Kopran cuts price of Nyte 17 March 2003 Zydus Cadila to launch new line of treatment for kala azar 15 March 2003 GlaxoSmithKline announces a dividend of Rs 7 per equity share 13 March 2003 Shasun launches Shacryl-30 D; gets US company’s licence 03 March 2003 India asked to lead battle against developed world on patent issue 26 February 2003 Major pharma companies in race for acquiring RPG Life Sciences 26 February 2003 Orchid Pharma's Cephalexin approved by USFDA, EDQM 24 February 2003 Medicine Shoppe, Bajaj Allianz to offer free insurance cover 24 February 2003 Argonne National Lab joins Joint Indo-American Bioinformatics 12 February 2003 Glenmark Pharmaceuticals to divest subsidiary for Rs 35 crore 10 February 2003 Share swap ratio of merger of Cadila, German Remedies at 7:4 05 February 2003 Orchid Chemicals net down to Rs 9.51 cr; turnover at 346.45 cr 28 January 2003 Novartis discontinues development of Dr Reddy’s compound 24 January 2003 Chemtech + Pharma World Expo to start in Mumbai on 22 Jan 18 January 2003 EMD Pharma awards Aker Kvaerner cell culture project 16 January 2003 DCGI asks ICMR to chart guidelines for stem-cell research 13 January 2003 Zydus Cadila, Berna Biotech tie up to develop cancer vaccines 13 January 2003 IDBI may bid again for strategic sell-off of Hind Antibiotics 11 January 2003 GlaxoSmithKline declares second interim dividend of 37% 21 December 2002 Sun Pharmaceuticals approves resolutions for split, buyback 21 December 2002 Orchid Chemicals acquires Mano Pharma, Sali Healthcare 17 December 2002 Novo Nordisk ignores IPR, to launch new products in India 13 December 2002 Multinational, domestic pharma firms lock horns over R&D data 09 December 2002 Caraco, Sun Pharma sign R&D pact for 25 new generic drugs 09 December 2002 Glaxo SmithKline defers merger with Burroughs Wellcome 09 December 2002 Ranbaxy to provide AIDS drugs to 10 lakh patients 29 November 2002 Gland Pharma sets up R&D centre near Hyderabad 28 November 2002 Alembic gets nod to market third-generation cephalosporin drug 27 November 2002 Morepen to reposition Dab range, add more flavour to C-Sip 19 November 2002 Alembic to diversify into speicalty chemicals, biotechnology 18 November 2002 BIFR, lenders reject IDBI bid to sell Hindustan Antibiotics 13 November 2002 Orchid Chemicals procures USFDA approval for Cephalexin 11 November 2002 Kopran promoters, FIs, banks offload 18% stake in company 08 November 2002 Novartis acquires global rights for Torrent’s AGE compound 07 November 2002 Hikal clocks 28% sales growth at Rs 32 crore in second quarter 31 October 2002 Cheryl’s Cosmetics to expand operations, to train professionals 29 October 2002 Sun Pharma clocks 12% turnover, 14% PAT increase in Q2 29 October 2002 Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit 18 October 2002 Morepen Laboratories net profit up to Rs 168 million in Q2 14 October 2002 Dr Reddy’s Labs to appeal US court ruling on infringement 14 October 2002 Boots Piramal to enter vitamins, minerals, food supplements 10 October 2002 India emerges hot market for human drug development testing 08 October 2002 Reliance Life Sciences develops stem cells to treat heart diseases 07 October 2002 Government likely to amend D&C Act to curb illicit drug trade 07 October 2002 SSI plans to launch BCG, rabies vaccines soon 04 October 2002 Ranbaxy secures 10% stake in Nihon Pharma 26 September 2002 Ranbaxy gets USFDA approval for Terazosin 26 September 2002 RPG Life unveils nephrocare pharma division 24 September 2002 Bayer recasts activities, gets into OTC sector 20 September 2002 DCI team clears Sun Pharma research facility 18 September 2002 Matrix to merge Vorin, Medicorp with itself 16 September 2002 Nicholas Piramal hikes its stake in JV by 9% 09 September 2002 Novartis sale of property to Kingston through 09 September 2002 Max India to exit pharmaceutical business 05 September 2002 Hikal, Rockwell in enterprise integration JV 02 September 2002 Dr Reddy’s grants employee stock options 27 August 2002 Ranbaxy refutes Glaxo’s charge of stealing 24 August 2002 Glaxo SmithKline to sue Novartis, Ranbaxy 23 August 2002 Himalaya unveils women’s healthcare drugs 23 August 2002 Alembic to launch new drug delivery system 05 August 2002 Ajanta net up 278%, exports zoom 358% 29 July 2002 Hikal net rises by 16%, thrust on pharma 24 July 2002 Ranbaxy acquires Signature Pharma facility 23 July 2002 Orchid Chemicals in equal JV with NCPC 20 July 2002 Magan Industries forays into biotech, pharma 17 July 2002 Orchid Chemicals to go slow on nutraceuticals 31 May 2002 Maharashtra FDA plans to apply GMP rules 22 May 2002 IAVI to begin human trials on HIV vaccine 22 May 2002 Unichem gets MCA nod for HP plant 18 March 2002 Astra open offer for Indian subsidiary 09 March 2002 In placebo limbo? 08 February 2002 Maharashtra hikes drug license fee 08 February 2002 Pharma sector fared well in 2001 28 December 2001 Kerala to preserve, promote ayurveda 24 December 2001 Zydus website on healthy lifestyle 15 December 2001 Sildenafil citrate drug sales surge 05 December 2001 in China 28 November 2001 Dr Reddys to challenge patents on drugs 26 November 2001 Iodex goes to SmithKline Healthcare 26 November 2001 Andhra Pradesh to set up Pharma City 23 November 2001 Alembic to rejig business operations 15 November 2001 Wockhardt files investigational application 15 November 2001 Rediscovering Indian pharma market 10 November 2001 Morepan to file nine drug applications 07 November 2001 Advanced anthrax vaccine developed 06 November 2001 Cadila Pharma gets US, UK patents 06 November 2001 Dr Reddys Labs launches Hyalosyn 06 November 2001 Sun Pharma to bifurcate subsidiary 03 November 2001 Zydus Alidac launches Bonmax 03 November 2001 Cipla comes under Sebi investigation 25 October 2001 Imunus launches 2 new Aids molecules 24 October 2001 Lupin to make HIV cocktail drugs 24 October 2001 Ranbaxy gets nod for Lisinopril 24 October 2001 Unichem in pact with IIS 24 October 2001 Pharma firms set to fight anthrax 16 October 2001 Aventis expects Arava to do well 12 October 2001 Caraco makes, markets two drugs in US 04 October 2001 Ajanta to offload stake in Kazakh firm 26 September 2001 Ajanta, Kopran drop plan to buy brands 20 September 2001 Zydus Cadila, Kopran join hands 18 September 2001 Chinese pharma units to face anti-dumping duty 17 September 2001 Oushadi to make veterinary medicines 14 September 2001 Dr Anji Reddy felicitated by IPA 28 June 2001 Pfizer joins hand with Microsoft and IBM for healthcare venture 05 April 2001 Drug major changes policy for AIDS drug 16 March 2001 Chemists prepare for face-off with manufacturers 16 March 2001 Abbott revives growth prospects with BASF acquisition 18 December 2000 Glaxo SmithKline reaches agreement with US FTC 18 December 2000 Eli Lilly arthritis drug deal a forerunner for acquisition ? 17 November 2000 Nycomed-Amersham to move research to China 14 November 2000 Popular medicines pulled out of shelves by regulators 14 November 2000 Pharma companies combine forces to battle spurious drugs 30 October 2000 List of bulk drugs under Drug Price Control Order 08 March 2000 NPPA slashes prices of two bulk drugs 08 March 2000 Zandu, CMI to jointly develop drug for Parkinson's disease 11 February 2000 US FDA to formulate new guidelines for botanicals 11 February 2000 Zandu has six more products in pipeline 11 February 2000 Pfizer acquires Warner Lambert 07 February 2000 Merger impact in India 07 February 2000 Global sales up nine per cent 19 January 2000 Glaxo Wellcome, SmithKline Beecham agree to merge 17 January 2000 Large market share 17 January 2000 Why the merger worked this time 17 January 2000 About Novopharm 13 January 2000 Ranbaxy to sell ranitidine 75mg tablets in the US 13 January 2000 The Medicine Shoppe 07 January 2000 Rationalising drug distribution in India 07 January 2000 Foreign investment limit raised to 74% 06 January 2000 Age-related macular degeneration 03 January 2000 Ajanta Pharma's drug for macular degeneration 03 January 2000 Abbreviated New Drug Application (ANDA) 01 January 2000 Distribution margins in India 01 January 2000 RDCA to form retail co-operative society in Mumbai 01 January 2000 Drug distribution channels 01 January 2000 Subiksha 01 January 2000 NPPA revises prices of 26 formulations 28 December 1999 Table of revised/fixed prices 28 December 1999 Marketing alliances can hurt 25 November 1999 Pharmaceutical exports up 3 per cent 16 November 1999 Ban on vitamins only on high-dose formulations 16 November 1999 Nicholas Piramal will gain from vitamin A price hike 10 November 1999 Vitamin A manufacturing process 10 November 1999 If Wyeth takes Parke Davis ... if Pfizer does? 06 November 1999 Vitamin A - unattractive business? 06 November 1999 Novartis, Nicholas to buy Hoechst units 16 October 1999 Hoechst keen on analgin exports 07 October 1999 Unichem eyeing analgesic brands 22 September 1999 Unichem financial highlights: 1998-99 22 September 1999 Unichem launches women's healthcare division 22 September 1999 Alpha drugs referred to BIFR 14 September 1999 Alpha drugs referred to BIFR 10 September 1999 Two views on controls 10 September 1999 Ranbaxy closes $65 million Bayer deal 09 September 1999 Ranbaxy to raise research spending to 6 per cent of sales by 2002 09 September 1999 Drug prices revised, Wockhardt to gain 13 August 1999 J&J hives off adhesives unit to Premchand group 12 August 1999 Norton Healthcare ties up with Nicholas Piramal, RPG Life Sciences 06 August 1999 India likely to attract clinical trials projects for new drugs 04 August 1999 Nicholas Piramal buys four Eli Lilly brands 22 July 1999 Ode to a visionary 04 July 1999 Hoechst, Nicholas Piramal to co-market two products 01 July 1999 Ranbaxy in talks with Bayer for licensing ciprofloxacin delivery system 25 June 1999 Dabur launches anti-hepatitis product 23 June 1999 Formulations grew 14% in 1998: IMS 21 June 1999 Glaxo, Ranbaxy, Cipla top rankings in 1998: IMS 21 June 1999 Glaxo, Ranbaxy, Cipla top rankings in 1998: IMS 21 June 1999 Contract manufacturing: new vistas for Indian pharma companies 14 June 1999 BIFR declares Paam Pharma sick 31 May 1999 Zandu's US trials for anti-Parkinson drug 31 May 1999 Ranbaxy pushes Pravosin to phase-1 trials 30 May 1999 Hoechst puts four brands on the block 29 May 1999 Bayer, Zydus end joint venture 21 May 1999 Glaxo acquires five veterinary brands from ICI 20 May 1999 Cheminor unfazed by AstraZeneca patent infringement suit 13 May 1999 Boots to sell Piramal ayurvedic products in Europe 12 May 1999 Ajanta, Ranbaxy plan co-marketing 27 April 1999 Wockhardt preparing for competition 27 April 1999 Aurobindo turns cold on Dee Pharma unit 24 April 1999 NPPA losses charm as govt clips price fixing powers 24 April 1999 Cipla eyes US generics market, in talks for alliance 22 April 1999 Parke-Davis to extend Benadryl brand name 22 April 1999 Zidovudine will boost Glaxo 22 April 1999 Abbott Labs diversifying 01 September 1998 Abbott's new businesses, low-cost oppurtunism 01 September 1998  search domain-b    go
Legal Policy | Copyright © 1999-2010 The Information Company Private Limited. All rights reserved.